{"ID": "B963C9D46D337AB9F6CCAB9F9EA6549D", "URL": "https://www.ema.europa.eu/documents/product-information/fendrix-epar-product-information_en.pdf", "Product_Name": "Fendrix", "Full_Content": "1 \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\nANNEX I \n \n\nSUMMARY OF PRODUCT CHARACTERISTICS \n \n\n\n\n 2  \n\n \n1. NAME OF THE MEDICINAL PRODUCT \n \nFendrix suspension for injection \nHepatitis B (rDNA) vaccine (adjuvanted, adsorbed).  \n \n \n2. QUALITATIVE AND QUANTITATIVE COMPOSITION  \n\n \n1 dose (0.5 ml) contains:  \n \nHepatitis B surface antigen 1, 2, 3 20 micrograms \n \n1adjuvanted by AS04C containing: \n\n- 3-O-desacyl-4\u2019- monophosphoryl lipid A (MPL) 2  50 micrograms \n \n\n2adsorbed on aluminium phosphate (0.5 milligrams Al3+ in total)  \n \n3produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology. \n \nFor the full list of excipients, see section 6.1 \n \n \n3. PHARMACEUTICAL FORM \n \nSuspension for injection. \n \nTurbid white suspension. Upon storage, a fine white deposit with a clear colourless supernatant can be \nobserved. \n \n \n4.  CLINICAL PARTICULARS \n \n4.1 Therapeutic indications \n \nFendrix is indicated in adolescents and adults from the age of 15 years onwards for active \nimmunisation against hepatitis B virus infection (HBV) caused by all known subtypes for patients with \nrenal insufficiency (including pre-haemodialysis and haemodialysis patients). \n \n4.2 Posology and method of administration \n \nPosology \n \nPrimary immunisation: \n \nThe primary immunisation consists of 4 separate 0.5 ml doses administered at the following schedule: \n1 month, 2 months and 6 months from the date of the first dose.  \n \nOnce initiated, the primary course of vaccination at 0, 1, 2 and 6 months should be completed with \nFendrix, and not with other commercially available HBV vaccine. \n \nBooster dose: \n \nAs pre-haemodialysis and haemodialysis patients are particularly exposed to HBV and have a higher \nrisk to become chronically infected, a precautionary attitude should be considered i.e. giving a booster \ndose in order to ensure a protective antibody level as defined by national recommendations and \nguidelines.  \n\n\n\n 3  \n\n \nFendrix can be used as a booster dose after a primary vaccination course with either Fendrix or any \nother commercial recombinant hepatitis B vaccine. \n \nSpecial posology recommendation for known or presumed exposure to HBV: \n \nData on concomitant administration of Fendrix with specific hepatitis B immunoglobulin (HBIg) have \nnot been generated. However, in circumstances where exposure to HBV has recently occurred (e.g. \nstick with contaminated needle) and where simultaneous administration of Fendrix and a standard \ndose of HBIg is necessary, these should be given at separate injection sites. \n \nPaediatric population \n \nThe safety and efficacy of Fendrix in children aged less than 15 years have not been established. \n \nMethod of administration \n \nFendrix should be injected intramuscularly in the deltoid region. \n \n4.3 Contraindications \n \nHypersensitivity to the active substance or to any of the excipients listed in section 6.1.  \n \nHypersensitivity after previous administration of other hepatitis B vaccines.  \n \nThe administration of Fendrix should be postponed in subjects suffering from acute severe febrile \nillness. The presence of a minor infection such as a cold, is not a contraindication for immunisation. \n \n4.4 Special warnings and precautions for use \n \nAs with all injectable vaccines, appropriate medical treatment and supervision should always be \nreadily available in case of rare anaphylactic reactions following the administration of the vaccine. \n \nBecause of the long incubation period of hepatitis B, it is possible that subjects could have been \ninfected before the time of immunisation. The vaccine may not prevent hepatitis B infection in such \ncases. \n \nThe vaccine will not prevent infection caused by other agents such as hepatitis A, hepatitis C and \nhepatitis E or other pathogens known to infect the liver. \n \nAs with any vaccine, a protective immune response may not be elicited in all vaccinees.  \n \nA number of factors have been observed to reduce the immune response to hepatitis B vaccines. These \nfactors include older age, male gender, obesity, smoking, route of administration, and some chronic \nunderlying diseases. Consideration should be given to serological testing of those subjects who may be \nat risk of not achieving seroprotection following a complete course of Fendrix. Additional doses may \nneed to be considered for subjects who do not respond or have a sub-optimal response to a course of \nvaccinations. \n \nSince intramuscular administration into the gluteal muscle could lead to a suboptimal response to the \nvaccine, this route should be avoided.   \n \nFendrix should under no circumstances be administered intradermally or intravenously. \n \nPatients with chronic liver disease or with HIV infection or hepatitis C carriers should not be \nprecluded from vaccination against hepatitis B. The vaccine could be advised since HBV infection can \n\n\n\n 4  \n\nbe severe in these patients: the Hepatitis B vaccination should thus be considered on a case-by-case \nbasis by the physician.  \n \nSyncope (fainting) can occur following, or even before, any vaccination especially in adolescents as a \npsychogenic response to the needle injection. This can be accompanied by several neurological signs \nsuch as transient visual disturbance, paraesthesia and tonic-clonic limb movements during recovery. It \nis important that procedures are in place to avoid injury from faints. \n \n4.5 Interaction with other medicinal products and other forms of interaction \n \nNo data on the concomitant administration of Fendrix and other vaccines or with specific hepatitis B \nimmunoglobulin have been generated. If concomitant administration of specific hepatitis B \nimmunoglobulin and Fendrix is required, these should be given at different injection sites. As no data \nare available for the concomitant administration of this particular vaccine with other vaccines, an \ninterval of 2 to 3 weeks should be respected. \n \nIt may be expected that in patients receiving immunosuppressive treatment or patients with \nimmunodeficiency, an adequate immune response may not be elicited. \n \n4.6 Fertility, pregnancy and lactation \n \nPregnancy \n \nThere are no data from the use of Fendrix in pregnant women. \nAnimal studies do not indicate direct or indirect harmful effects with respect to pregnancy, \nembryonal/foetal development, parturition or postnatal development. \nVaccination during pregnancy should only be performed if the risk-benefit ratio at individual level \noutweighs possible risks for the foetus. \n \nBreast-feeding \n \nThere are no data from use of Fendrix during lactation. In a reproductive toxicity study in animals \nwhich included post-natal follow-up until weaning (see section 5.3), no effect on the development of \nthe pups was observed.  Vaccination should only be performed if the risk-benefit ratio at individual \nlevel outweighs possible risks for the infant. \n \nFertility \n \nNo fertility data are available. \n \n4.7 Effects on ability to drive and use machines \n \nFendrix has moderate influence on the ability to drive and use machine.  \n \nSome of the undesirable effects mentioned under section 4.8 may affect the ability to drive or use \nmachines. \n \n4.8 Undesirable effects  \n \nSummary of the safety profile \n\n\n\n 5  \n\n \nClinical trials involving the administration of 2,476 doses of Fendrix to 82 pre-haemodialysis and \nhaemodialysis patients and to 713 healthy subjects \u2265 15 years of age allowed to document the \nreactogenicity of the vaccine.  \n \nPre-haemodialysis and haemodialysis patients \n \nThe reactogenicity profile of Fendrix in a total of 82 pre-haemodialysis and haemodialysis patients \nwas generally comparable to that seen in healthy subjects.  \n \nList of adverse reactions \n \nAdverse reactions reported in a clinical trial following primary vaccination with Fendrix and \nconsidered as being related or possibly related to vaccination have been categorised by frequency. \n \nFrequencies are reported as: \nVery common: (\u22651/10) \nCommon: (\u22651/100 to <1/10) \nUncommon: (\u22651/1,000 to <1/100) \nRare:   (\u22651/10,000 to <1/1,000) \nVery rare:  (<1/10,000) \n \nClinical trial data \n \nNervous system disorders: \nVery common: headache \n \nGastrointestinal disorders: \nCommon: gastrointestinal disorder \n \nGeneral disorders and administration site conditions: \nVery common: fatigue, pain  \nCommon: fever, injection site swelling, redness  \n \nUnsolicited symptoms considered to be at least possibly related to vaccination were uncommonly \nreported and consisted of rigors, other injection site reaction and maculo-papular rash. \n \nHealthy subjects \n \nThe reactogenicity profile of Fendrix in healthy subjects was generally comparable to that seen in pre-\nhaemodialysis and haemodialysis patients.  \n \nIn a large double-blind randomised comparative study, healthy subjects were enrolled to receive a \nthree dose primary course of Fendrix (N= 713) or a commercially available hepatitis B vaccine       \n(N= 238) at 0, 1, 2 months. The most common adverse reactions reported were local reactions at the \ninjection site.  \nVaccination with Fendrix induced more transient local symptoms as compared to the comparator \nvaccine, with pain at the injection site being the most frequently reported solicited local symptom. \nHowever, solicited general symptoms were observed with similar frequencies in both groups.  \n \nAdverse reactions reported in a clinical trial following primary vaccination with Fendrix and \nconsidered as being at least possibly related to vaccination have been categorised by frequency.  \n \nNervous system disorders: \nCommon: headache \n \nEar and labyrinth disorders: \n\n\n\n 6  \n\nRare: vertigo \n \nGastrointestinal disorders: \nCommon: gastrointestinal disorder \n \nMuskuloskeletal and connective tissue disorders: \nRare: tendinitis, back pain \n \nInfections and infestations: \nRare: viral infection  \n \nGeneral disorders and administration site conditions: \nVery common: injection site swelling, fatigue, pain, redness \nCommon: fever  \nUncommon: other injection site reaction \nRare: rigors, hot flushes, thirst, asthenia \n \nImmune system disorders: \nRare: allergy \n \nPsychiatric disorders: \nRare: nervousness \n \nNo increase in the incidence or severity of these adverse reactions was seen with subsequent doses of \nthe primary vaccination schedule.  \n \nNo increase in the reactogenicity was observed after the booster vaccination with respect to the \nprimary vaccination.  \n \n\u2022 Experience with hepatitis B vaccine: \n \nFollowing widespread use of hepatitis B vaccines, in very rare cases, syncope, paralysis, neuropathy, \nneuritis (including Guillain-Barr\u00e9 syndrome, optic neuritis and multiple sclerosis), encephalitis, \nencephalopathy, meningitis and convulsions have been reported.  The causal relationship to the \nvaccine has not been established. \n \nAnaphylaxis, allergic reactions including anaphylactoid reactions and mimicking serum sickness have \nalso been reported very rarely with hepatitis B vaccines. \n \nReporting of suspected adverse reactions \nReporting suspected adverse reactions after authorisation of the medicinal product is important. It \nallows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare \nprofessionals are asked to report any suspected adverse reactions via the national reporting system \nlisted in Appendix V. \n \n4.9 Overdose \n \nLimited data on overdose are available.  \n \n \n5.  PHARMACOLOGICAL PROPERTIES \n \n5.1 Pharmacodynamic properties \n \nPharmacotherapeutic group: Vaccines, hepatitis vaccines, ATC code J07BC01. \n \n\nhttp://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\n\n\n 7  \n\nFendrix induces specific humoral antibodies against HBsAg (anti-HBs antibodies).  An anti-HBs \nantibody titre \u2265 10 mIU/ml correlates with protection to HBV infection. \n \nIt can be expected that hepatitis D will also be prevented by immunisation with Fendrix as hepatitis D \n(caused by the delta agent) does not occur in the absence of hepatitis B infection. \n \nImmunological data \n \nIn pre-haemodialysis and haemodialysis patients: \nIn a comparative clinical study in 165 pre-haemodialysis and haemodialysis patients (15 years and \nabove), protective levels of specific humoral antibodies (anti-HBs titres \u2265 10 mIU/ml) were observed \nin 74.4% of Fendrix recipients (N = 82) one month after the third dose (i.e at month 3), as compared to \n52.4% of patients in the control group who received a double dose of a commercially available \nhepatitis B vaccine (N = 83) for this population. \n\n \nAt month 3, Geometric Mean Titres (GMT) were 223.0 mIU/ml and 50.1 mIU/ml in the Fendrix and \ncontrol groups respectively, with 41.0% and 15.9% of subjects with anti-HBs antibody titres \u2265100 \nmIU/ml respectively. \n\n \nAfter completion of a four dose primary course (i.e at month 7), 90.9% of Fendrix recipients were \nseroprotected (\u2265 10 mIU/ml) against hepatitis B, in comparison with 84.4% in a control group who \nreceived the commercially available hepatitis B vaccine. \n\n \nAt month 7, GMTs were 3559.2 mIU/ml and 933.0 mIU/ml in the Fendrix and control groups who \nreceived the commercially available hepatitis B vaccine respectively, with 83.1% and 67.5% of \nsubjects with anti-HBs antibody titres \u2265100 mIU/ml respectively. \n \nAntibody persistence \n \nIn pre-haemodialysis and haemodialysis patients: \nAnti-HBs antibodies have been shown to persist for at least 36 months following a 0, 1, 2, 6 month \nprimary course of Fendrix in pre-haemodialysis and haemodialysis patients. At month 36, 80.4% of \nthese patients retained protective antibody levels (anti-HBs titres  \u2265 10mIU/ml), as compared to 51.3% \nof patients who received a commercially available hepatitis B vaccine. \n \nAt month 36, GMTs were 154.1 mIU/ml and 111.9 mIU/ml in the Fendrix and control groups \nrespectively, with 58.7% and 38.5% of subjects with anti-HBs antibody titres \u2265100 mIU/ml \nrespectively. \n \n5.2 Pharmacokinetic properties \n \nPharmacokinetic properties of Fendrix or MPL alone has not been studied in humans. \n \n5.3 Preclinical safety data \n \nNon-clinical data reveal no special hazard for humans based on conventional animal studies consisting \nof acute and repeated dose toxicity, cardiovascular and respiratory safety pharmacology and \nreproductive toxicity including pregnancy and peri and postnatal development of the pups till weaning \n(see section 4.6). \n \n \n6.  PHARMACEUTICAL PARTICULARS \n \n6.1 List of excipients \n \nSodium chloride \nWater for injections  \n\n\n\n 8  \n\n \nFor adjuvants, see section 2. \n \n6.2 Incompatibilities \n \nIn the absence of compatibility studies, this medicinal product must not be mixed with other medicinal \nproducts. \n \n6.3 Shelf life \n \n3 years. \n \n6.4 Special precautions for storage \n \nStore in a refrigerator (2\u00b0C \u2013 8\u00b0C). \n \nDo not freeze. \n \nStore in the original package in order to protect from light. \n \n6.5 Nature and contents of container \n \n0.5 ml of suspension in pre-filled syringe (type I glass) with a plunger stopper (rubber butyl) with or \nwithout separate needle in a pack size of 1, or without needles in a pack size of 10. \nNot all pack sizes may be marketed. \n  \n6.6 Special precautions for disposal and other handling \n \nUpon storage, a fine white deposit with a clear colourless supernatant can be observed.   \n \nBefore administration, the vaccine should be well shaken to obtain a slightly opaque, white \nsuspension. \n \nThe vaccine should be visually inspected both before and after re-suspension for any foreign \nparticulate matter and/or change in physical appearance. The vaccine must not be used if any change \nin the appearance of the vaccine has taken place. \n \nAny unused medicinal product or waste material should be disposed of in accordance with local \nrequirements. \n \n \n7. MARKETING AUTHORISATION HOLDER \n \nGlaxoSmithKline Biologicals s.a. \nRue de l'Institut 89 \nB-1330 Rixensart, Belgium \n \n \n8.  MARKETING AUTHORISATION NUMBER(S) \n \nEU/1/04/0299/001 \nEU/1/04/0299/002 \nEU/1/04/0299/003 \n \n \n9.  DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION \n \n\n\n\n 9  \n\nDate of first authorisation: 02 February 2005 \nDate of latest renewal: 10 December 2009 \n \n \n10. DATE OF REVISION OF THE TEXT \n \nDetailed information on this product is available on the website of the European Medicines Agency  \nhttp://www.ema.europa.eu \n\n\n\n 10  \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\nANNEX II \n \nA. MANUFACTURER OF THE BIOLOGICAL ACTIVE \n\nSUBSTANCE AND MANUFACTURER RESPONSIBLE FOR \nBATCH RELEASE \n\n \nB. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY \n\nAND USE \n \n\nC. OTHER CONDITIONS AND REQUIREMENTS OF THE \nMARKETING AUTHORISATION \n\n \nD. CONDITIONS OR RESTRICTIONS WITH REGARD TO \n\nTHE SAFE AND EFFECTIVE USE OF THE MEDICINAL \nPRODUCT \n\n \n\n\n\n 11  \n\n \nA MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND \n\nMANUFACTURER RESPONSIBLE FOR BATCH RELEASE \n \nName and address of the manufacturer of the biological active substance \n \nGlaxoSmithKline Biologicals S.A. \n89, rue de l\u2019Institut \u2013 1330 Rixensart \nBelgium \n \nName and address of the manufacturer responsible for batch release \n \nGlaxoSmithKline Biologicals S.A. \n89, rue de l\u2019Institut \u2013 1330 Rixensart \nBelgium \n \n \nB CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE \n \nMedicinal product subject to medical prescription \n \n\u2022 Official batch release \n \nIn accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken \nby a state laboratory or a laboratory designated for that purpose. \n \n \nC. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING \n\nAUTHORISATION \n \n\u2022 Periodic Safety Update Reports \n \nThe marketing authorisation holder shall submit periodic safety update reports for this product in \naccordance with the requirements set out in the list of Union reference dates (EURD list) provided for \nunder Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal. \n \n \nD. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND \n\nEFFECTIVE USE OF THE MEDICINAL PRODUCT \n \n\u2022 Risk Management Plan (RMP) \n \nNot applicable.\n\n\n\n 12  \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\nANNEX III \n \n\nLABELLING AND PACKAGE LEAFLET \n \n\n\n\n 13  \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\nA. LABELLING \n \n\n\n\n 14  \n\n \nPARTICULARS TO APPEAR ON THE OUTER PACKAGING \n \n1 PRE-FILLED SYRINGE WITH SEPARATE NEEDLE \n1 PRE-FILLED SYRINGE WITHOUT NEEDLE \n10 PRE-FILLED SYRINGES WITHOUT NEEDLES \n \n \n1. NAME OF THE MEDICINAL PRODUCT \n \nFendrix suspension for injection \nHepatitis B (rDNA) vaccine (adjuvanted, adsorbed) \n \n \n2. STATEMENT OF ACTIVE SUBSTANCE(S) \n \n1 dose (0.5 ml):  \nHepatitis B surface antigen1, 2, 3 20 micrograms \n \n1adjuvanted by AS04C containing: \n\n- 3-O-desacyl-4\u2019- monophosphoryl lipid A (MPL) 2  50 micrograms \n \n\n2adsorbed on aluminium phosphate (0.5 milligrams Al3+ in total)  \n \n3produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology \n \n \n3. LIST OF EXCIPIENTS \n \nSodium chloride \nWater for injections  \n \n \n4. PHARMACEUTICAL FORM AND CONTENTS \n \nSuspension for injection \n \n1 pre-filled syringe \n1 separate needle \n1 dose (0.5 ml) \n \n1 pre-filled syringe \n1 dose (0.5 ml) \n \n10 pre-filled syringes \n1 dose (0.5 ml) \n \n \n5. METHOD AND ROUTE(S) OF ADMINISTRATION \n \nIntramuscular use \nShake well before use \nRead the package leaflet before use \n \n \n\n\n\n 15  \n\n6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT \nOF THE SIGHT AND REACH OF CHILDREN \n\n \nKeep out of the sight and reach of children \n \n \n7. OTHER SPECIAL WARNING(S), IF NECESSARY \n \n \n8. EXPIRY DATE \n \nEXP \n \n \n9. SPECIAL STORAGE CONDITIONS \n \nStore in a refrigerator \nDo not freeze \nStore in the original package in order to protect from light \n \n \n10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS \n\nOR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF \nAPPROPRIATE \n\n \n \n \n11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER \n \nGlaxoSmithKline Biologicals s.a. \nRue de l\u2019Institut 89 \nB-1330 Rixensart, Belgium \n \n \n12. MARKETING AUTHORISATION NUMBER(S) \n \nEU/1/04/0299/001 \u2013 pack of 1 with separate needle \nEU/1/04/0299/002 \u2013 pack of 1 without needle \nEU/1/04/0299/003 \u2013 pack of 10 without needles \n \n \n13. BATCH NUMBER \n \nLot \n \n \n14. GENERAL CLASSIFICATION FOR SUPPLY \n \n \n \n15. INSTRUCTIONS ON USE \n \n \n16. INFORMATION IN BRAILLE \n\n\n\n 16  \n\n \nJustification for not including Braille accepted. \n \n \n17. UNIQUE IDENTIFIER \u2013 2D BARCODE \n \n2D barcode carrying the unique identifier included. \n \n \n18. UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA \n \nPC: \nSN: \nNN: \n \n\n\n\n 17  \n\n \nMINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS \n \n \nPREFILLED SYRINGE \n \n \n1. NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION \n \nFendrix suspension for injection \nIM \n \n \n2. METHOD OF ADMINISTRATION \n \n \n3. EXPIRY DATE \n \nEXP  \n \n \n4. BATCH NUMBER \n \nLot  \n \n \n5. CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT \n \n1 dose (0.5 ml) \n \n \n6. OTHER \n \n\n\n\n 18  \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\nB. PACKAGE LEAFLET \n \n\n\n\n 19  \n\n \nPackage leaflet: Information for the user \n\n \nFendrix suspension for injection \n\nHepatitis B (rDNA) vaccine (adjuvanted, adsorbed) \n \nRead all of this leaflet carefully before you receive this vaccine because it contains important \ninformation for you. \n\u2022 Keep this leaflet. You may need to read it again. \n\u2022 If you have any further questions, ask your doctor or pharmacist. \n\u2022 This vaccine has been prescribed for you only. Do not pass it on to others. \n\u2022 If you get any side effects, talk to your doctor or pharmacist. This includes any possible side \n\neffects not listed in this leaflet. See section 4. \n \nWhat is in this leaflet: \n1. What Fendrix is and what it is used for \n2. What you need to know before you receive Fendrix  \n3. How Fendrix is given \n4. Possible side effects \n5. How to store Fendrix \n6. Contents of the pack and other information \n \n \n1. What Fendrix is and what it is used for \n \nFendrix is a vaccine which prevents hepatitis B.  \nIt is used for patients with kidney problems: \n\u2022 patients having \u201chaemo-dialysis\u201d- where a \u201cdialysis\u201d machine removes waste products from the \n\nblood \n\u2022 patients who are going to have \u201chaemo-dialysis\u201d in the future. \n \nFendrix is for adults and young people aged 15 years and above. \n \nWhat is hepatitis B? \n \nHepatitis B is caused by a virus which makes the liver swollen.   \n\u2022 Signs may not be seen for 6 weeks to 6 months after infection. \n\u2022 The main signs of the illness include mild signs of flu such as headache or fever, feeling very \n\ntired, dark urine, pale stools (faeces), yellow skin or eyes (jaundice). These or other signs may \nmean the person might need treatment in hospital. Most people fully recover from the illness. \n\n\u2022 Some people with hepatitis B do not look or feel ill - they do not have any signs of illness. \n\u2022 The virus is found in body fluids such as in the vagina, blood, semen, or saliva (spit). \n \nCarriers of hepatitis B \n \n\u2022 The hepatitis B virus stays in the body of some people all through their lives. \n\u2022 This means they can still infect other people and are known as virus \u201ccarriers\u201d. \n\u2022 Carriers of the virus are likely to get serious liver problems, such as \u201ccirrhosis\u201d or liver cancer. \n \nHow Fendrix works \n \n\u2022 Fendrix helps your body to produce its own protection against the virus (antibodies). These \n\nantibodies will protect you against the disease. \n\u2022 Fendrix contains two things called \u201cMPL\u201d (a non-toxic purified fat derivative from bacteria) and \n\n\u201caluminium phosphate\u201d. These make the vaccine work quicker, better and last for longer. \n\u2022 As with all vaccines, a course of Fendrix cannot fully protect all people that are vaccinated. \n\n\n\n 20  \n\n\u2022 Fendrix may not protect you from being ill if you have already caught the hepatitis B virus. \n\u2022 Fendrix can only help to protect you against infection with the hepatitis B virus. It cannot protect \n\nyou against other infections that can affect the liver - even though these infections might have \nsigns similar to those caused by the hepatitis B virus. \n\n \n \n2.  What you need to know before you receive Fendrix \n \nFendrix should not be given \n \n\u2022 if you are allergic to the active substance, or any of the other ingredients of this vaccine (listed \n\nin section 6). Signs of an allergic reaction may include itchy skin rash, shortness of breath and \nswelling of the face or tongue \n\n\u2022 if you have ever had an allergic reaction to any vaccine against hepatitis B \n\u2022 if you have a severe infection with a high temperature. The vaccine can be given after you have \n\nrecovered. A minor infection such as a cold should not be a problem, but talk to your doctor \nfirst. \n \n\nFendrix should not be given if any of the above apply to you. If you are not sure, talk to your doctor or \npharmacist before having Fendrix. \n \nWarnings and precautions \n \nTalk to your doctor or pharmacist before you are given Fendrix: \n \n\u2022 if you have any known allergies \n\u2022 if you have had any health problems after having a vaccine in the past. \n \nFainting can occur (mostly in adolescents) following, or even before, any needle injection. Therefore \ntell the doctor or nurse if you fainted with a previous injection. \n \nIf any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before having \nFendrix. \n \nOther medicines and Fendrix \n \nTell your doctor if you are taking, have recently taken, might take any other medicines or have \nrecently received any other vaccine. \n \n\u2022 You should have a gap of at least 2 to 3 weeks between having Fendrix and any other vaccine. \n\u2022 Fendrix may need to be given at the same time as an injection of hepatitis B \u201cimmuno-globulins\u201d. \n\nYour doctor will make sure that the vaccines are injected into different parts of the body. \n \nPregnancy, breast-feeding and fertility \n \nIf you are pregnant or breast-feeding, think that you may be pregnant or are planning to have a baby, \nask your doctor for advice before you are given this vaccine. \n \nDriving and using machines \n \nYou may feel tired or get a headache after receiving Fendrix. If this happens, take special care while \ndriving or using any tools or machines. \n \n \n3. How Fendrix is given \n \nHow the vaccine is given \n\n\n\n 21  \n\nThe doctor or nurse will give Fendrix as an injection into your muscle. This is usually in your upper \narm. \n \nHow much is given \n\u2022 You will have a series of four injections. \n\u2022 The injections will be given within 6 months: \n\n- First injection   - on a date agreed with your doctor. \n- Second injection  - 1 month after the first injection. \n- Third injection   - 2 months after the first injection. \n- Fourth injection   - 6 months after the first injection. \n\n \n\u2022 The doctor or nurse will tell you when you should come back for the next injections. \n \n\u2022 Once you have had the first injection of Fendrix, the next injections need also to be Fendrix (not \n\nanother sort of hepatitis B vaccine). \n \nYour doctor will tell you if you need any extra or \u201cbooster\u201d injections in the future. Fendrix can also \nbe used as a booster after a course of a different type of hepatitis B vaccine. \n \nIf you miss a dose \n \n\u2022 If you miss an injection, talk to your doctor and arrange another visit. \n\u2022 Make sure you finish the complete course of four injections. If not, you may not be fully protected \n\nagainst the disease. \n \n \n4.  Possible side effects \n \nLike all medicines, this vaccine can cause side effects, although not everybody gets them. \n \nThe following side effects may happen with this vaccine. Their frequency is defined using the \nconventions listed below: \n \nVery common (these may occur with more than 1 in 10 doses of the vaccine)  \n\n\u2022 headache   \n\u2022 feeling tired \n\u2022 pain or discomfort where the injection was given. \n\n \nCommon (these may occur with up to 1 in 10 doses of the vaccine) \n\n\u2022 redness or swelling where the injection was given  \n\u2022 fever  \n\u2022 stomach and digestion problems. \n\n \nUncommon (these may occur with up to 1 in 100 doses of the vaccine) \n\n\u2022 chills  \n\u2022 red, raised skin rash  \n\u2022 other reactions where the injection was given. \n\n \nRare (these may occur with up to 1 in 1,000 doses of the vaccine) \n\n\u2022 allergy  \n\u2022 hot flushes  \n\u2022 feeling dizzy  \n\u2022 feeling thirsty \n\u2022 feeling nervous  \n\u2022 infection caused by a virus \n\u2022 back pain, swelling of your tendons. \n\n\n\n 22  \n\n \nAdditionally, the following side effects have also been reported with other hepatitis B vaccines: \n \nVery rare (these may occur with up to 1 in 10,000 doses of the vaccine) \n\n\u2022 fits \n\u2022 fainting \n\u2022 problems with the nerves of your eye (optic neuritis) \n\u2022 multiple sclerosis \n\u2022 loss of feeling or problems moving some parts of your body \n\u2022 severe headache with a stiff neck \n\u2022 numbness or weakness of the arms and legs (neuropathy), inflammation of nerves \n\n(neuritis), weakness and paralysis in the extremities and often progressing to the chest and \nface (Guillain-Barr\u00e9 syndrome), swelling or infection of the brain (encephalitis, \nencephalopathy). \n\n\u2022 allergic reactions, including anaphylactoid reactions.  These may be local or widespread \nrashes that may be itchy or blistering, swelling of the eyes and face, difficulty in breathing \nor swallowing, a sudden drop in blood pressure and loss of consciousness.  Such reactions \nmay occur before leaving the doctor\u2019s surgery.  However, you should seek immediate \ntreatment in any event.  \n\n \nReporting of side effects \nIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects \nnot listed in this leaflet. You can also report side effects directly via the national reporting system \nlisted in Appendix V. By reporting side effects you can help provide more information on the safety of \nthis medicine. \n \n \n5.  How to store Fendrix \n \n\u2022 Keep this vaccine out of the sight and reach of children. \n \n\u2022 Do not use this vaccine after the expiry date which is stated on the carton. The expiry date refers \n\nto the last day of that month. \n \n\u2022 Store in a refrigerator (2\u00b0C - 8\u00b0C). \n\u2022 Store in the original package in order to protect from light. \n\u2022 Do not freeze.  Freezing destroys the vaccine. \n \n\u2022 Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how \n\nto throw away medicines you no longer use. These measures will help to protect the environment. \n \n \n6. Contents of the pack and other information \n \nWhat Fendrix contains \n \n\u2022 The active substance in 1 dose (0.5 ml) of Fendrix is:  \n \nHepatitis B surface antigen 1, 2, 3 20 micrograms \n \n1adjuvanted by AS04C containing: \n\n- 3-O-desacyl-4\u2019- monophosphoryl lipid A (MPL) 2  50 micrograms \n \n2adsorbed on aluminium phosphate (0.5 milligrams Al3+ in total)  \n \n3produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology. \n\n\n\n 23  \n\n \n\u2022 The other ingredients in Fendrix are: sodium chloride, water for injections.  \n \nWhat Fendrix looks like and contents of the pack \n \n\u2022 Suspension for injection in a prefilled syringe. \n \n\u2022 Fendrix is a white, milky suspension presented in a glass prefilled syringe (0.5 ml). \n \n\u2022 Fendrix is available in packs of 1 (with or without a separate needle) and in a pack size of 10 \n\nwithout needles. \n \n\u2022 Not all pack sizes may be marketed. \n \nMarketing Authorisation Holder and Manufacturer: \n \nGlaxoSmithKline Biologicals s.a. \nRue de l\u2019Institut 89 \nB-1330 Rixensart \nBelgium \n \nFor any information about this medicine, please contact the local representative of the Marketing \nAuthorisation holder. \n \nBelgi\u00eb/Belgique/Belgien \nGlaxoSmithKline Pharmaceuticals s.a./n.v. \nT\u00e9l/Tel: + 32 10 85 52 00 \n \n\nLietuva \nGlaxoSmithKline Lietuva UAB \nTel. +370 5 264 90 00 \ninfo.lt@gsk.com \n \n\n\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f \n\u0413\u043b\u0430\u043a\u0441\u043e\u0421\u043c\u0438\u0442\u041a\u043b\u0430\u0439\u043d \u0415\u041e\u041e\u0414 \n\u0422\u0435\u043b. + 359 2 953 10 34 \n\nLuxembourg/Luxemburg \nGlaxoSmithKline Pharmaceuticals s.a./n.v. \nT\u00e9l/Tel: + 32 10 85 52 00 \n\n \n\u010cesk\u00e1 republika \nGlaxoSmithKline s.r.o. \nTel: + 420 2 22 00 11 11 \ncz.info@gsk.com \n \n\n \nMagyarorsz\u00e1g \nGlaxoSmithKline Kft. \nTel.: + 36-1-2255300 \n\nDanmark \nGlaxoSmithKline Pharma A/S \nTlf: + 45 36 35 91 00 \ndk-info@gsk.com \n \n\nMalta \nGlaxoSmithKline (Malta) Ltd \nTel: + 356 21 238131 \n \n\nDeutschland \nGlaxoSmithKline GmbH & Co. KG \nTel: + 49 (0)89 360448701 \nprodukt.info@gsk.com \n \n\nNederland \nGlaxoSmithKline BV \nTel: + 31 (0)30 69 38 100 \nnlinfo@gsk.com \n \n\nEesti \nGlaxoSmithKline Eesti O\u00dc  \nTel: +372 667 6900 \nestonia@gsk.com \n \n\nNorge \nGlaxoSmithKline AS \nTlf: + 47 22 70 20 00 \nfirmapost@gsk.no \n \n \n\n\u0395\u03bb\u03bb\u03ac\u03b4\u03b1 \nGlaxoSmithKline A.E.B.E. \nT\u03b7\u03bb: + 30 210 68 82 100 \n\n\u00d6sterreich \nGlaxoSmithKline Pharma GmbH. \nTel: + 43 1 970 75-0 \n\n\n\n 24  \n\n at.info@gsk.com \n \nEspa\u00f1a \nGlaxoSmithKline, S.A. \nTel: + 34 902 202 700 \nes-ci@gsk.com  \n \n\n \nPolska \nGSK Services Sp. z o.o. \nTel.: + 48 (22) 576 9000 \n \n\nFrance \nLaboratoire GlaxoSmithKline \nT\u00e9l: + 33 (0) 1 39 17 84 44 \ndiam@gsk.com \n \n \nHrvatska \nGlaxoSmithKline d.o.o. \nTel.: + 385 (0)1 6051999 \n \n\nPortugal \nSmith Kline & French Portuguesa - Produtos \nFarmac\u00eauticos, Lda. \nTel: + 351 21 412 95 00 \nFI.PT@gsk.com \n \nRom\u00e2nia \nGlaxoSmithKline (GSK) SRL \nTel: +40 (0)21 3028 208 \n \n\nIreland \nGlaxoSmithKline (Ireland) Ltd \nTel: + 353 (0)1 495 5000 \n \n\nSlovenija \nGlaxoSmithKline d.o.o. \nTel: + 386 (0) 1 280 25 00 \nmedical.x.si@gsk.com \n \n\n\u00cdsland \nVistor hf.  \nS\u00edmi: +354 535 7000 \n\nSlovensk\u00e1 republika \nGlaxoSmithKline Slovakia s.r.o. \nTel: + 421 (0)2 48 26 11 11 \nrecepcia.sk@gsk.com \n \n\nItalia \nGlaxoSmithKline S.p.A. \nTel: + 39 04 59 21 81 11 \n \n\nSuomi/Finland \nGlaxoSmithKline Oy \nPuh/Tel: + 358 10 30 30 30 \nFinland.tuoteinfo@gsk.com  \n \n\n\u039a\u03cd\u03c0\u03c1\u03bf\u03c2 \nGlaxoSmithKline (Cyprus) Ltd \n\u03a4\u03b7\u03bb: + 357 22 39 70 00 \ngskcyprus@gsk.com \n \n\nSverige \nGlaxoSmithKline AB \nTel: + 46 (0)8 638 93 00 \ninfo.produkt@gsk.com \n\nLatvija \nGlaxoSmithKline Latvia SIA \nTel: + 371 67312687 \nlv-epasts@gsk.com \n \n\nUnited Kingdom \nGlaxoSmithKline UK \nTel: +44 (0)800 221 441 \ncustomercontactuk@gsk.com \n \n\n  \n \nThis leaflet was last revised in  \n \nOther sources of information \n \nDetailed information on this medicine is available on the European Medicines Agency web site: \nhttp://www.ema.europa.eu \n---------------------------------------------------------------------------------------------------------------------- \n \nThe following information is intended for healthcare professionals only: \n \nUpon storage, a fine white deposit with a clear colourless supernatant can be observed.  \n \n\nmailto:gskcyprus@gsk.com\n\n\n 25  \n\nBefore administration, the vaccine should be well shaken to obtain a slightly opaque, white \nsuspension. \n \nThe vaccine should be visually inspected both before and after re-suspension for any foreign \nparticulate matter and/or change in physical appearance.  The vaccine must not be used if any change \nin the appearance of the vaccine has taken place. \n \nAny unused medicinal product or waste material should be disposed of in accordance with local \nrequirements. \n \nFendrix should not be given to subjects with hypersensitivity to the active substance or to any of the \nexcipients.  \n \nFendrix should not be given to subjects with hypersensitivity after previous administration of other \nhepatitis B vaccines.  \n \nFendrix should not be given to subjects suffering from acute severe febrile illness.  The presence of a \nminor infection such as a cold, is not a contraindication for immunisation. \n \nFendrix should be injected intramuscularly in the deltoid region. \n \nSince intramuscular administration into the gluteal muscle could lead to a suboptimal response to the \nvaccine, this route should be avoided.   \n \nFendrix should under no circumstances be administered intradermally or intravenously. \n \nAs pre-haemodialysis and haemodialysis patients are particularly exposed to HBV and have a higher \nrisk to become chronically infected, a precautionary attitude should be considered i.e. giving a booster \ndose in order to ensure a protective antibody level as defined by national recommendations and \nguidelines.  \n \nAppropriate medical treatment should always be readily available in case of rare anaphylactic \nreactions following the administration of the vaccine. \n \n\n\n\tSUMMARY OF PRODUCT CHARACTERISTICS\n\tA MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE\n\tB CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE\n\tC. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION\n\tD. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT\n\n\tA. LABELLING\n\tB. PACKAGE LEAFLET\n\n<<\r\n  /ASCII85EncodePages false\r\n  /AllowTransparency false\r\n  /AutoPositionEPSFiles true\r\n  /AutoRotatePages /None\r\n  /Binding /Left\r\n  /CalGrayProfile (Dot Gain 20%)\r\n  /CalRGBProfile (sRGB IEC61966-2.1)\r\n  /CalCMYKProfile (U.S. Web Coated \\050SWOP\\051 v2)\r\n  /sRGBProfile (sRGB IEC61966-2.1)\r\n  /CannotEmbedFontPolicy /Error\r\n  /CompatibilityLevel 1.4\r\n  /CompressObjects /Tags\r\n  /CompressPages true\r\n  /ConvertImagesToIndexed true\r\n  /PassThroughJPEGImages true\r\n  /CreateJobTicket false\r\n  /DefaultRenderingIntent /Default\r\n  /DetectBlends true\r\n  /DetectCurves 0.0000\r\n  /ColorConversionStrategy /CMYK\r\n  /DoThumbnails false\r\n  /EmbedAllFonts true\r\n  /EmbedOpenType false\r\n  /ParseICCProfilesInComments true\r\n  /EmbedJobOptions true\r\n  /DSCReportingLevel 0\r\n  /EmitDSCWarnings false\r\n  /EndPage -1\r\n  /ImageMemory 1048576\r\n  /LockDistillerParams false\r\n  /MaxSubsetPct 100\r\n  /Optimize true\r\n  /OPM 1\r\n  /ParseDSCComments true\r\n  /ParseDSCCommentsForDocInfo true\r\n  /PreserveCopyPage true\r\n  /PreserveDICMYKValues true\r\n  /PreserveEPSInfo true\r\n  /PreserveFlatness true\r\n  /PreserveHalftoneInfo false\r\n  /PreserveOPIComments true\r\n  /PreserveOverprintSettings true\r\n  /StartPage 1\r\n  /SubsetFonts true\r\n  /TransferFunctionInfo /Apply\r\n  /UCRandBGInfo /Preserve\r\n  /UsePrologue false\r\n  /ColorSettingsFile ()\r\n  /AlwaysEmbed [ true\r\n  ]\r\n  /NeverEmbed [ true\r\n  ]\r\n  /AntiAliasColorImages false\r\n  /CropColorImages true\r\n  /ColorImageMinResolution 300\r\n  /ColorImageMinResolutionPolicy /OK\r\n  /DownsampleColorImages true\r\n  /ColorImageDownsampleType /Bicubic\r\n  /ColorImageResolution 300\r\n  /ColorImageDepth -1\r\n  /ColorImageMinDownsampleDepth 1\r\n  /ColorImageDownsampleThreshold 1.50000\r\n  /EncodeColorImages true\r\n  /ColorImageFilter /DCTEncode\r\n  /AutoFilterColorImages true\r\n  /ColorImageAutoFilterStrategy /JPEG\r\n  /ColorACSImageDict <<\r\n    /QFactor 0.15\r\n    /HSamples [1 1 1 1] /VSamples [1 1 1 1]\r\n  >>\r\n  /ColorImageDict <<\r\n    /QFactor 0.15\r\n    /HSamples [1 1 1 1] /VSamples [1 1 1 1]\r\n  >>\r\n  /JPEG2000ColorACSImageDict <<\r\n    /TileWidth 256\r\n    /TileHeight 256\r\n    /Quality 30\r\n  >>\r\n  /JPEG2000ColorImageDict <<\r\n    /TileWidth 256\r\n    /TileHeight 256\r\n    /Quality 30\r\n  >>\r\n  /AntiAliasGrayImages false\r\n  /CropGrayImages true\r\n  /GrayImageMinResolution 300\r\n  /GrayImageMinResolutionPolicy /OK\r\n  /DownsampleGrayImages true\r\n  /GrayImageDownsampleType /Bicubic\r\n  /GrayImageResolution 300\r\n  /GrayImageDepth -1\r\n  /GrayImageMinDownsampleDepth 2\r\n  /GrayImageDownsampleThreshold 1.50000\r\n  /EncodeGrayImages true\r\n  /GrayImageFilter /DCTEncode\r\n  /AutoFilterGrayImages true\r\n  /GrayImageAutoFilterStrategy /JPEG\r\n  /GrayACSImageDict <<\r\n    /QFactor 0.15\r\n    /HSamples [1 1 1 1] /VSamples [1 1 1 1]\r\n  >>\r\n  /GrayImageDict <<\r\n    /QFactor 0.15\r\n    /HSamples [1 1 1 1] /VSamples [1 1 1 1]\r\n  >>\r\n  /JPEG2000GrayACSImageDict <<\r\n    /TileWidth 256\r\n    /TileHeight 256\r\n    /Quality 30\r\n  >>\r\n  /JPEG2000GrayImageDict <<\r\n    /TileWidth 256\r\n    /TileHeight 256\r\n    /Quality 30\r\n  >>\r\n  /AntiAliasMonoImages false\r\n  /CropMonoImages true\r\n  /MonoImageMinResolution 1200\r\n  /MonoImageMinResolutionPolicy /OK\r\n  /DownsampleMonoImages true\r\n  /MonoImageDownsampleType /Bicubic\r\n  /MonoImageResolution 1200\r\n  /MonoImageDepth -1\r\n  /MonoImageDownsampleThreshold 1.50000\r\n  /EncodeMonoImages true\r\n  /MonoImageFilter /CCITTFaxEncode\r\n  /MonoImageDict <<\r\n    /K -1\r\n  >>\r\n  /AllowPSXObjects false\r\n  /CheckCompliance [\r\n    /None\r\n  ]\r\n  /PDFX1aCheck false\r\n  /PDFX3Check false\r\n  /PDFXCompliantPDFOnly false\r\n  /PDFXNoTrimBoxError true\r\n  /PDFXTrimBoxToMediaBoxOffset [\r\n    0.00000\r\n    0.00000\r\n    0.00000\r\n    0.00000\r\n  ]\r\n  /PDFXSetBleedBoxToMediaBox true\r\n  /PDFXBleedBoxToTrimBoxOffset [\r\n    0.00000\r\n    0.00000\r\n    0.00000\r\n    0.00000\r\n  ]\r\n  /PDFXOutputIntentProfile ()\r\n  /PDFXOutputConditionIdentifier ()\r\n  /PDFXOutputCondition ()\r\n  /PDFXRegistryName ()\r\n  /PDFXTrapped /False\r\n\r\n  /CreateJDFFile false\r\n  /Description <<\r\n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r\n    /BGR <FEFF04180437043f043e043b043704320430043904420435002004420435043704380020043d0430044104420440043e0439043a0438002c00200437043000200434043000200441044a0437043404300432043004420435002000410064006f00620065002000500044004600200434043e043a0443043c0435043d04420438002c0020043c0430043a04410438043c0430043b043d043e0020043f044004380433043e04340435043d04380020043704300020043204380441043e043a043e043a0430044704350441044204320435043d0020043f04350447043004420020043704300020043f044004350434043f0435044704300442043d04300020043f043e04340433043e0442043e0432043a0430002e002000200421044a04370434043004340435043d043804420435002000500044004600200434043e043a0443043c0435043d044204380020043c043e0433043004420020043404300020044104350020043e0442043204300440044f0442002004410020004100630072006f00620061007400200438002000410064006f00620065002000520065006100640065007200200035002e00300020043800200441043b0435043404320430044904380020043204350440044104380438002e>\r\n    /CHS <FEFF4f7f75288fd94e9b8bbe5b9a521b5efa7684002000410064006f006200650020005000440046002065876863900275284e8e9ad88d2891cf76845370524d53705237300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c676562535f00521b5efa768400200050004400460020658768633002>\r\n    /CHT <FEFF4f7f752890194e9b8a2d7f6e5efa7acb7684002000410064006f006200650020005000440046002065874ef69069752865bc9ad854c18cea76845370524d5370523786557406300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c4f86958b555f5df25efa7acb76840020005000440046002065874ef63002>\r\n    /CZE <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>\r\n    /DAN <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>\r\n    /DEU <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>\r\n    /ESP <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>\r\n    /ETI <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>\r\n    /FRA <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>\r\n    /GRE <FEFF03a703c103b703c303b903bc03bf03c003bf03b903ae03c303c403b5002003b103c503c403ad03c2002003c403b903c2002003c103c503b803bc03af03c303b503b903c2002003b303b903b1002003bd03b1002003b403b703bc03b903bf03c503c103b303ae03c303b503c403b5002003ad03b303b303c103b103c603b1002000410064006f006200650020005000440046002003c003bf03c5002003b503af03bd03b103b9002003ba03b103c42019002003b503be03bf03c703ae03bd002003ba03b103c403ac03bb03bb03b703bb03b1002003b303b903b1002003c003c103bf002d03b503ba03c403c503c003c903c403b903ba03ad03c2002003b503c103b303b103c303af03b503c2002003c503c803b703bb03ae03c2002003c003bf03b903cc03c403b703c403b103c2002e0020002003a403b10020005000440046002003ad03b303b303c103b103c603b1002003c003bf03c5002003ad03c703b503c403b5002003b403b703bc03b903bf03c503c103b303ae03c303b503b9002003bc03c003bf03c103bf03cd03bd002003bd03b1002003b103bd03bf03b903c703c403bf03cd03bd002003bc03b5002003c403bf0020004100630072006f006200610074002c002003c403bf002000410064006f00620065002000520065006100640065007200200035002e0030002003ba03b103b9002003bc03b503c403b103b303b503bd03ad03c303c403b503c103b503c2002003b503ba03b403cc03c303b503b903c2002e>\r\n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r\n    /HRV (Za stvaranje Adobe PDF dokumenata najpogodnijih za visokokvalitetni ispis prije tiskanja koristite ove postavke.  Stvoreni PDF dokumenti mogu se otvoriti Acrobat i Adobe Reader 5.0 i kasnijim verzijama.)\r\n    /HUN <FEFF004b0069007600e1006c00f30020006d0069006e0151007300e9006701710020006e0079006f006d00640061006900200065006c0151006b00e90073007a00ed007401510020006e0079006f006d00740061007400e100730068006f007a0020006c006500670069006e006b00e1006200620020006d0065006700660065006c0065006c0151002000410064006f00620065002000500044004600200064006f006b0075006d0065006e00740075006d006f006b0061007400200065007a0065006b006b0065006c0020006100200062006500e1006c006c00ed007400e10073006f006b006b0061006c0020006b00e90073007a00ed0074006800650074002e0020002000410020006c00e90074007200650068006f007a006f00740074002000500044004600200064006f006b0075006d0065006e00740075006d006f006b00200061007a0020004100630072006f006200610074002000e9007300200061007a002000410064006f00620065002000520065006100640065007200200035002e0030002c0020007600610067007900200061007a002000610074007400f3006c0020006b00e9007301510062006200690020007600650072007a006900f3006b006b0061006c0020006e00790069007400680061007400f3006b0020006d00650067002e>\r\n    /ITA <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>\r\n    /JPN <FEFF9ad854c18cea306a30d730ea30d730ec30b951fa529b7528002000410064006f0062006500200050004400460020658766f8306e4f5c6210306b4f7f75283057307e305930023053306e8a2d5b9a30674f5c62103055308c305f0020005000440046002030d530a130a430eb306f3001004100630072006f0062006100740020304a30883073002000410064006f00620065002000520065006100640065007200200035002e003000204ee5964d3067958b304f30533068304c3067304d307e305930023053306e8a2d5b9a306b306f30d530a930f330c8306e57cb30818fbc307f304c5fc59808306730593002>\r\n    /KOR <FEFFc7740020c124c815c7440020c0acc6a9d558c5ec0020ace0d488c9c80020c2dcd5d80020c778c1c4c5d00020ac00c7a50020c801d569d55c002000410064006f0062006500200050004400460020bb38c11cb97c0020c791c131d569b2c8b2e4002e0020c774b807ac8c0020c791c131b41c00200050004400460020bb38c11cb2940020004100630072006f0062006100740020bc0f002000410064006f00620065002000520065006100640065007200200035002e00300020c774c0c1c5d0c11c0020c5f40020c2180020c788c2b5b2c8b2e4002e>\r\n    /LTH <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>\r\n    /LVI <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>\r\n    /NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die zijn geoptimaliseerd voor prepress-afdrukken van hoge kwaliteit. De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 5.0 en hoger.)\r\n    /NOR <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>\r\n    /POL <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>\r\n    /PTB <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>\r\n    /RUM <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>\r\n    /RUS <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>\r\n    /SKY <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>\r\n    /SLV <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>\r\n    /SUO <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>\r\n    /SVE <FEFF0041006e007600e4006e00640020006400650020006800e4007200200069006e0073007400e4006c006c006e0069006e006700610072006e00610020006f006d002000640075002000760069006c006c00200073006b006100700061002000410064006f006200650020005000440046002d0064006f006b0075006d0065006e007400200073006f006d002000e400720020006c00e4006d0070006c0069006700610020006600f60072002000700072006500700072006500730073002d007500740073006b00720069006600740020006d006500640020006800f600670020006b00760061006c0069007400650074002e002000200053006b006100700061006400650020005000440046002d0064006f006b0075006d0065006e00740020006b0061006e002000f600700070006e00610073002000690020004100630072006f0062006100740020006f00630068002000410064006f00620065002000520065006100640065007200200035002e00300020006f00630068002000730065006e006100720065002e>\r\n    /TUR <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>\r\n    /UKR <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>\r\n    /ENU (Use these settings to create Adobe PDF documents best suited for high-quality prepress printing.  Created PDF documents can be opened with Acrobat and Adobe Reader 5.0 and later.)\r\n  >>\r\n  /Namespace [\r\n    (Adobe)\r\n    (Common)\r\n    (1.0)\r\n  ]\r\n  /OtherNamespaces [\r\n    <<\r\n      /AsReaderSpreads false\r\n      /CropImagesToFrames true\r\n      /ErrorControl /WarnAndContinue\r\n      /FlattenerIgnoreSpreadOverrides false\r\n      /IncludeGuidesGrids false\r\n      /IncludeNonPrinting false\r\n      /IncludeSlug false\r\n      /Namespace [\r\n        (Adobe)\r\n        (InDesign)\r\n        (4.0)\r\n      ]\r\n      /OmitPlacedBitmaps false\r\n      /OmitPlacedEPS false\r\n      /OmitPlacedPDF false\r\n      /SimulateOverprint /Legacy\r\n    >>\r\n    <<\r\n      /AddBleedMarks false\r\n      /AddColorBars false\r\n      /AddCropMarks false\r\n      /AddPageInfo false\r\n      /AddRegMarks false\r\n      /ConvertColors /ConvertToCMYK\r\n      /DestinationProfileName ()\r\n      /DestinationProfileSelector /DocumentCMYK\r\n      /Downsample16BitImages true\r\n      /FlattenerPreset <<\r\n        /PresetSelector /MediumResolution\r\n      >>\r\n      /FormElements false\r\n      /GenerateStructure false\r\n      /IncludeBookmarks false\r\n      /IncludeHyperlinks false\r\n      /IncludeInteractive false\r\n      /IncludeLayers false\r\n      /IncludeProfiles false\r\n      /MultimediaHandling /UseObjectSettings\r\n      /Namespace [\r\n        (Adobe)\r\n        (CreativeSuite)\r\n        (2.0)\r\n      ]\r\n      /PDFXOutputIntentProfileSelector /DocumentCMYK\r\n      /PreserveEditing true\r\n      /UntaggedCMYKHandling /LeaveUntagged\r\n      /UntaggedRGBHandling /UseDocumentProfile\r\n      /UseDocumentBleed false\r\n    >>\r\n  ]\r\n>> setdistillerparams\r\n<<\r\n  /HWResolution [2400 2400]\r\n  /PageSize [612.000 792.000]\r\n>> setpagedevice", "Section_1": {"Title": "1. what fendrix is and what it is used for", "Section_Content": "fendrix is a vaccine which prevents hepatitis b. it is used for patients with kidney problems: patients having \"haemo-dialysis\"- where a \"dialysis\" machine removes waste products from the blood patients who are going to have \"haemo-dialysis\" in the future. fendrix is for adults and young people aged 15 years and above. what is hepatitis b? hepatitis b is caused by a virus which makes the liver swollen. signs may not be seen for 6 weeks to 6 months after infection. the main signs of the illness include mild signs of flu such as headache or fever, feeling very tired, dark urine, pale stools (faeces), yellow skin or eyes (jaundice). these or other signs may mean the person might need treatment in hospital. most people fully recover from the illness. some people with hepatitis b do not look or feel ill - they do not have any signs of illness. the virus is found in body fluids such as in the vagina, blood, semen, or saliva (spit). carriers of hepatitis b the hepatitis b virus stays in the body of some people all through their lives. this means they can still infect other people and are known as virus \"carriers\". carriers of the virus are likely to get serious liver problems, such as \"cirrhosis\" or liver cancer. how fendrix works fendrix helps your body to produce its own protection against the virus (antibodies). these antibodies will protect you against the disease. fendrix contains two things called \"mpl\" (a non-toxic purified fat derivative from bacteria) and \"aluminium phosphate\". these make the vaccine work quicker, better and last for longer. as with all vaccines, a course of fendrix cannot fully protect all people that are vaccinated. fendrix may not protect you from being ill if you have already caught the hepatitis b virus. fendrix can only help to protect you against infection with the hepatitis b virus. it cannot protect you against other infections that can affect the liver - even though these infections might have signs similar to those caused by the hepatitis b virus.", "Entity_Recognition": [{"Text": "fendrix", "Type": "PRODUCT_NAME", "BeginOffset": 0, "EndOffset": 0}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 0, "EndOffset": 7}, {"Text": "a vaccine", "Type": "TREATMENT", "BeginOffset": 11, "EndOffset": 20}, {"Text": "hepatitis b.", "Type": "PROBLEM", "BeginOffset": 36, "EndOffset": 48}, {"Id": 9, "BeginOffset": 78, "EndOffset": 93, "Score": 0.8615173101425171, "Text": "kidney problems", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.7743341326713562}]}, {"Id": 35, "BeginOffset": 112, "EndOffset": 117, "Score": 0.42771220207214355, "Text": "haemo", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Id": 36, "BeginOffset": 118, "EndOffset": 126, "Score": 0.8751271963119507, "Text": "dialysis", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Text": "a \"dialysis\" machine", "Type": "TREATMENT", "BeginOffset": 135, "EndOffset": 155}, {"Id": 38, "BeginOffset": 226, "EndOffset": 231, "Score": 0.29768335819244385, "Text": "haemo", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Id": 39, "BeginOffset": 232, "EndOffset": 240, "Score": 0.8394743800163269, "Text": "dialysis", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Id": 42, "BeginOffset": 242, "EndOffset": 255, "Score": 0.7313222289085388, "Text": "in the future", "Category": "TIME_EXPRESSION", "Type": "TIME_TO_TREATMENT_NAME", "Traits": [], "Attributes": [{"Type": "TREATMENT_NAME", "Score": 0.8394743800163269, "RelationshipScore": 0.9563460946083069, "RelationshipType": "OVERLAP", "Id": 39, "BeginOffset": 232, "EndOffset": 240, "Text": "dialysis", "Category": "TEST_TREATMENT_PROCEDURE", "Traits": []}]}, {"Id": 10, "BeginOffset": 257, "EndOffset": 264, "Score": 0.5006746649742126, "Text": "fendrix", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": []}, {"Id": 33, "BeginOffset": 301, "EndOffset": 303, "Score": 0.17479699850082397, "Text": "15", "Category": "PROTECTED_HEALTH_INFORMATION", "Type": "AGE", "Traits": []}, {"Id": 11, "BeginOffset": 329, "EndOffset": 340, "Score": 0.6069047451019287, "Text": "hepatitis b", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.7855764031410217}]}, {"Id": 12, "BeginOffset": 342, "EndOffset": 353, "Score": 0.5099954009056091, "Text": "hepatitis b", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.5897216796875}]}, {"Text": "a virus", "Type": "PROBLEM", "BeginOffset": 367, "EndOffset": 374}, {"Text": "the liver swollen", "Type": "PROBLEM", "BeginOffset": 387, "EndOffset": 404}, {"Id": 43, "BeginOffset": 432, "EndOffset": 451, "Score": 0.8088892102241516, "Text": "6 weeks to 6 months", "Category": "TIME_EXPRESSION", "Type": "TIME_TO_DX_NAME", "Traits": [], "Attributes": [{"Type": "DX_NAME", "Score": 0.974389374256134, "RelationshipScore": 0.5059180855751038, "RelationshipType": "OVERLAP", "Id": 14, "BeginOffset": 458, "EndOffset": 467, "Text": "infection", "Category": "MEDICAL_CONDITION", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.7311097979545593}]}]}, {"Text": "6", "Type": "NUMBER", "BeginOffset": 443, "EndOffset": 444}, {"Id": 14, "BeginOffset": 458, "EndOffset": 467, "Score": 0.974389374256134, "Text": "infection", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.7311097979545593}]}, {"Text": "the illness", "Type": "PROBLEM", "BeginOffset": 487, "EndOffset": 498}, {"Id": 15, "BeginOffset": 521, "EndOffset": 524, "Score": 0.8159164190292358, "Text": "flu", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.6992864608764648}]}, {"Id": 16, "BeginOffset": 533, "EndOffset": 541, "Score": 0.9980033040046692, "Text": "headache", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.9290763139724731}]}, {"Id": 17, "BeginOffset": 545, "EndOffset": 550, "Score": 0.9982032775878906, "Text": "fever", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.9275631308555603}]}, {"Id": 18, "BeginOffset": 552, "EndOffset": 570, "Score": 0.5809124112129211, "Text": "feeling very tired", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.9478845000267029}]}, {"Id": 19, "BeginOffset": 572, "EndOffset": 582, "Score": 0.9697533845901489, "Text": "dark urine", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.9260739088058472}]}, {"Id": 20, "BeginOffset": 584, "EndOffset": 595, "Score": 0.8760842084884644, "Text": "pale stools", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8678754568099976}]}, {"Id": 2, "BeginOffset": 597, "EndOffset": 603, "Score": 0.3317544460296631, "Text": "faeces", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Text": "yellow skin or eyes (jaundice", "Type": "PROBLEM", "BeginOffset": 606, "EndOffset": 635}, {"Text": "treatment", "Type": "TREATMENT", "BeginOffset": 690, "EndOffset": 699}, {"Text": "the illness", "Type": "PROBLEM", "BeginOffset": 744, "EndOffset": 755}, {"Id": 23, "BeginOffset": 774, "EndOffset": 809, "Score": 0.5376237630844116, "Text": "hepatitis b do not look or feel ill", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8768192529678345}, {"Name": "NEGATION", "Score": 0.7634923458099365}]}, {"Id": 24, "BeginOffset": 842, "EndOffset": 849, "Score": 0.5264005064964294, "Text": "illness", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "NEGATION", "Score": 0.6497995257377625}]}, {"Text": "the virus", "Type": "PROBLEM", "BeginOffset": 851, "EndOffset": 860}, {"Id": 5, "BeginOffset": 900, "EndOffset": 906, "Score": 0.7939395308494568, "Text": "vagina", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Text": "saliva", "Type": "PROBLEM", "BeginOffset": 925, "EndOffset": 931}, {"Text": "hepatitis b", "Type": "PROBLEM", "BeginOffset": 952, "EndOffset": 963}, {"Text": "the hepatitis b virus", "Type": "PROBLEM", "BeginOffset": 964, "EndOffset": 985}, {"Text": "the virus", "Type": "PROBLEM", "BeginOffset": 1137, "EndOffset": 1146}, {"Text": "serious liver problems", "Type": "PROBLEM", "BeginOffset": 1165, "EndOffset": 1187}, {"Text": "\"cirrhosis\"", "Type": "PROBLEM", "BeginOffset": 1197, "EndOffset": 1208}, {"Id": 29, "BeginOffset": 1212, "EndOffset": 1224, "Score": 0.9071466326713562, "Text": "liver cancer", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.9669294357299805}]}, {"Text": "the virus (antibodies)", "Type": "PROBLEM", "BeginOffset": 1306, "EndOffset": 1328}, {"Text": "these antibodies", "Type": "TREATMENT", "BeginOffset": 1330, "EndOffset": 1346}, {"Text": "the disease", "Type": "PROBLEM", "BeginOffset": 1372, "EndOffset": 1383}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 1385, "EndOffset": 1392}, {"Text": "a non-toxic purified fat derivative", "Type": "TREATMENT", "BeginOffset": 1427, "EndOffset": 1462}, {"Text": "bacteria", "Type": "PROBLEM", "BeginOffset": 1468, "EndOffset": 1476}, {"Text": "\"aluminium phosphate\"", "Type": "TREATMENT", "BeginOffset": 1482, "EndOffset": 1503}, {"Text": "all vaccines", "Type": "TREATMENT", "BeginOffset": 1578, "EndOffset": 1590}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 1604, "EndOffset": 1611}, {"Id": 41, "BeginOffset": 1653, "EndOffset": 1663, "Score": 0.29952555894851685, "Text": "vaccinated", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 1665, "EndOffset": 1672}, {"Text": "the hepatitis b virus", "Type": "PROBLEM", "BeginOffset": 1735, "EndOffset": 1756}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 1758, "EndOffset": 1765}, {"Id": 31, "BeginOffset": 1803, "EndOffset": 1812, "Score": 0.9616188406944275, "Text": "infection", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.8707676529884338}]}, {"Text": "the hepatitis b virus", "Type": "PROBLEM", "BeginOffset": 1818, "EndOffset": 1839}, {"Text": "other infections", "Type": "PROBLEM", "BeginOffset": 1871, "EndOffset": 1887}, {"Id": 44, "BeginOffset": 1908, "EndOffset": 1913, "Score": 0.9702506065368652, "Text": "liver", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Text": "these infections", "Type": "PROBLEM", "BeginOffset": 1928, "EndOffset": 1944}, {"Text": "the hepatitis b virus", "Type": "PROBLEM", "BeginOffset": 1989, "EndOffset": 2010}]}, "Section_2": {"Title": "2. what you need to know before you receive fendrix", "Section_Content": "fendrix should not be given if you are allergic to the active substance, or any of the other ingredients of this vaccine (listed in section 6). signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue if you have ever had an allergic reaction to any vaccine against hepatitis b if you have a severe infection with a high temperature. the vaccine can be given after you have recovered. a minor infection such as a cold should not be a problem, but talk to your doctor first. fendrix should not be given if any of the above apply to you. if you are not sure, talk to your doctor or pharmacist before having fendrix. warnings and precautions talk to your doctor or pharmacist before you are given fendrix: if you have any known allergies if you have had any health problems after having a vaccine in the past. fainting can occur (mostly in adolescents) following, or even before, any needle injection. therefore tell the doctor or nurse if you fainted with a previous injection. if any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before having fendrix. other medicines and fendrix tell your doctor if you are taking, have recently taken, might take any other medicines or have recently received any other vaccine. you should have a gap of at least 2 to 3 weeks between having fendrix and any other vaccine. fendrix may need to be given at the same time as an injection of hepatitis b \"immuno-globulins\". your doctor will make sure that the vaccines are injected into different parts of the body. pregnancy, breast-feeding and fertility if you are pregnant or breast-feeding, think that you may be pregnant or are planning to have a baby, ask your doctor for advice before you are given this vaccine. driving and using machines you may feel tired or get a headache after receiving fendrix. if this happens, take special care while driving or using any tools or machines.", "Entity_Recognition": [{"Text": "fendrix", "Type": "PRODUCT_NAME", "BeginOffset": 0, "EndOffset": 0}, {"Id": 11, "BeginOffset": 0, "EndOffset": 7, "Score": 0.40979158878326416, "Text": "fendrix", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": []}, {"Text": "allergic", "Type": "PROBLEM", "BeginOffset": 39, "EndOffset": 47}, {"Text": "this vaccine", "Type": "TREATMENT", "BeginOffset": 108, "EndOffset": 120}, {"Text": "an allergic reaction", "Type": "PROBLEM", "BeginOffset": 153, "EndOffset": 173}, {"Id": 13, "BeginOffset": 186, "EndOffset": 201, "Score": 0.46997231245040894, "Text": "itchy skin rash", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.7625985145568848}]}, {"Id": 0, "BeginOffset": 192, "EndOffset": 196, "Score": 0.975252628326416, "Text": "skin", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Id": 14, "BeginOffset": 203, "EndOffset": 222, "Score": 0.9966953992843628, "Text": "shortness of breath", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.9151263236999512}]}, {"Text": "swelling of the face or tongue", "Type": "PROBLEM", "BeginOffset": 227, "EndOffset": 257}, {"Text": "an allergic reaction", "Type": "PROBLEM", "BeginOffset": 279, "EndOffset": 299}, {"Text": "any vaccine", "Type": "TREATMENT", "BeginOffset": 303, "EndOffset": 314}, {"Id": 5, "BeginOffset": 323, "EndOffset": 334, "Score": 0.49135860800743103, "Text": "hepatitis b", "Category": "MEDICATION", "Type": "GENERIC_NAME", "Traits": []}, {"Text": "a severe infection", "Type": "PROBLEM", "BeginOffset": 347, "EndOffset": 365}, {"Text": "a high temperature", "Type": "PROBLEM", "BeginOffset": 371, "EndOffset": 389}, {"Text": "the vaccine", "Type": "TREATMENT", "BeginOffset": 391, "EndOffset": 402}, {"Text": "a minor infection", "Type": "PROBLEM", "BeginOffset": 442, "EndOffset": 459}, {"Id": 20, "BeginOffset": 470, "EndOffset": 474, "Score": 0.46172845363616943, "Text": "cold", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": []}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 531, "EndOffset": 538}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 662, "EndOffset": 669}, {"Id": 6, "BeginOffset": 751, "EndOffset": 758, "Score": 0.43764641880989075, "Text": "fendrix", "Category": "MEDICATION", "Type": "BRAND_NAME", "Traits": []}, {"Text": "any known allergies", "Type": "PROBLEM", "BeginOffset": 772, "EndOffset": 791}, {"Text": "a vaccine", "Type": "TREATMENT", "BeginOffset": 841, "EndOffset": 850}, {"Id": 40, "BeginOffset": 851, "EndOffset": 862, "Score": 0.9999951124191284, "Text": "in the past", "Category": "TIME_EXPRESSION", "Type": "TIME_TO_TREATMENT_NAME", "Traits": [], "Attributes": [{"Type": "TREATMENT_NAME", "Score": 0.556196391582489, "RelationshipScore": 0.992676854133606, "RelationshipType": "OVERLAP", "Id": 32, "BeginOffset": 843, "EndOffset": 850, "Text": "vaccine", "Category": "TEST_TREATMENT_PROCEDURE", "Traits": []}]}, {"Id": 21, "BeginOffset": 864, "EndOffset": 872, "Score": 0.8714298605918884, "Text": "fainting", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.6563392877578735}]}, {"Text": "any needle injection", "Type": "TREATMENT", "BeginOffset": 934, "EndOffset": 954}, {"Id": 22, "BeginOffset": 998, "EndOffset": 1005, "Score": 0.7654217481613159, "Text": "fainted", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.4952608048915863}]}, {"Text": "a previous injection", "Type": "TREATMENT", "BeginOffset": 1011, "EndOffset": 1031}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 1137, "EndOffset": 1144}, {"Text": "other medicines", "Type": "TREATMENT", "BeginOffset": 1146, "EndOffset": 1161}, {"Id": 7, "BeginOffset": 1166, "EndOffset": 1173, "Score": 0.3340899646282196, "Text": "fendrix", "Category": "MEDICATION", "Type": "BRAND_NAME", "Traits": []}, {"Id": 42, "BeginOffset": 1270, "EndOffset": 1278, "Score": 0.9999691247940063, "Text": "recently", "Category": "TIME_EXPRESSION", "Type": "TIME_TO_TREATMENT_NAME", "Traits": [], "Attributes": [{"Type": "TREATMENT_NAME", "Score": 0.6888947486877441, "RelationshipScore": 0.6501728892326355, "RelationshipType": "OVERLAP", "Id": 35, "BeginOffset": 1298, "EndOffset": 1305, "Text": "vaccine", "Category": "TEST_TREATMENT_PROCEDURE", "Traits": []}]}, {"Text": "any other vaccine", "Type": "TREATMENT", "BeginOffset": 1288, "EndOffset": 1305}, {"Text": "2", "Type": "NUMBER", "BeginOffset": 1341, "EndOffset": 1342}, {"Text": "3", "Type": "NUMBER", "BeginOffset": 1346, "EndOffset": 1347}, {"Id": 23, "BeginOffset": 1369, "EndOffset": 1376, "Score": 0.6175118684768677, "Text": "fendrix", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": []}, {"Text": "any other vaccine", "Type": "TREATMENT", "BeginOffset": 1381, "EndOffset": 1398}, {"Id": 8, "BeginOffset": 1400, "EndOffset": 1407, "Score": 0.27238729596138, "Text": "fendrix", "Category": "MEDICATION", "Type": "BRAND_NAME", "Traits": []}, {"Id": 37, "BeginOffset": 1452, "EndOffset": 1461, "Score": 0.24628609418869019, "Text": "injection", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "PROCEDURE_NAME", "Traits": []}, {"Id": 9, "BeginOffset": 1465, "EndOffset": 1494, "Score": 0.7052430510520935, "Text": "hepatitis b \"immuno-globulins", "Category": "MEDICATION", "Type": "GENERIC_NAME", "Traits": []}, {"Text": "the vaccines", "Type": "TREATMENT", "BeginOffset": 1529, "EndOffset": 1541}, {"Id": 3, "BeginOffset": 1583, "EndOffset": 1587, "Score": 0.5990561842918396, "Text": "body", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Id": 25, "BeginOffset": 1589, "EndOffset": 1598, "Score": 0.9560750126838684, "Text": "pregnancy", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.9385740756988525}]}, {"Id": 26, "BeginOffset": 1640, "EndOffset": 1648, "Score": 0.9910504817962646, "Text": "pregnant", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.9458870887756348}]}, {"Id": 27, "BeginOffset": 1690, "EndOffset": 1698, "Score": 0.9932836294174194, "Text": "pregnant", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.944857120513916}]}, {"Text": "this vaccine", "Type": "TREATMENT", "BeginOffset": 1779, "EndOffset": 1791}, {"Id": 28, "BeginOffset": 1833, "EndOffset": 1838, "Score": 0.9670059084892273, "Text": "tired", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8181688785552979}]}, {"Text": "a headache", "Type": "PROBLEM", "BeginOffset": 1846, "EndOffset": 1856}, {"Id": 10, "BeginOffset": 1873, "EndOffset": 1880, "Score": 0.7291705012321472, "Text": "fendrix", "Category": "MEDICATION", "Type": "BRAND_NAME", "Traits": []}]}, "Section_3": {"Title": "3. how fendrix is given", "Section_Content": "how the vaccine is given 21 the doctor or nurse will give fendrix as an injection into your muscle. this is usually in your upper arm. how much is given you will have a series of four injections. the injections will be given within 6 months: - first injection - on a date agreed with your doctor. - second injection - 1 month after the first injection. - third injection - 2 months after the first injection. - fourth injection - 6 months after the first injection. the doctor or nurse will tell you when you should come back for the next injections. once you have had the first injection of fendrix, the next injections need also to be fendrix (not another sort of hepatitis b vaccine). your doctor will tell you if you need any extra or \"booster\" injections in the future. fendrix can also be used as a booster after a course of a different type of hepatitis b vaccine. if you miss a dose if you miss an injection, talk to your doctor and arrange another visit. make sure you finish the complete course of four injections. if not, you may not be fully protected against the disease.", "Entity_Recognition": [{"Text": "fendrix", "Type": "PRODUCT_NAME", "BeginOffset": 0, "EndOffset": 0}, {"Text": "the vaccine", "Type": "TREATMENT", "BeginOffset": 4, "EndOffset": 15}, {"Text": "21", "Type": "NUMBER", "BeginOffset": 25, "EndOffset": 27}, {"Id": 3, "BeginOffset": 58, "EndOffset": 65, "Score": 0.7996775507926941, "Text": "fendrix", "Category": "MEDICATION", "Type": "BRAND_NAME", "Traits": [], "Attributes": [{"Type": "ROUTE_OR_MODE", "Score": 0.4267357587814331, "RelationshipScore": 0.9999949932098389, "RelationshipType": "ROUTE_OR_MODE", "Id": 4, "BeginOffset": 72, "EndOffset": 81, "Text": "injection", "Category": "MEDICATION", "Traits": []}]}, {"Id": 11, "BeginOffset": 72, "EndOffset": 81, "Score": 0.38663777709007263, "Text": "injection", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "PROCEDURE_NAME", "Traits": []}, {"Id": 0, "BeginOffset": 92, "EndOffset": 98, "Score": 0.9430605173110962, "Text": "muscle", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Id": 2, "BeginOffset": 130, "EndOffset": 133, "Score": 0.9762577414512634, "Text": "arm", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Text": "a series of four injections", "Type": "TREATMENT", "BeginOffset": 167, "EndOffset": 194}, {"Text": "the injections", "Type": "TREATMENT", "BeginOffset": 196, "EndOffset": 210}, {"Id": 30, "BeginOffset": 225, "EndOffset": 240, "Score": 0.9259423613548279, "Text": "within 6 months", "Category": "TIME_EXPRESSION", "Type": "TIME_TO_PROCEDURE_NAME", "Traits": [], "Attributes": [{"Type": "PROCEDURE_NAME", "Score": 0.6013414263725281, "RelationshipScore": 0.5227823257446289, "RelationshipType": "OVERLAP", "Id": 14, "BeginOffset": 250, "EndOffset": 259, "Text": "injection", "Category": "TEST_TREATMENT_PROCEDURE", "Traits": []}]}, {"Text": "6", "Type": "NUMBER", "BeginOffset": 232, "EndOffset": 233}, {"Id": 14, "BeginOffset": 250, "EndOffset": 259, "Score": 0.6013414263725281, "Text": "injection", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "PROCEDURE_NAME", "Traits": []}, {"Text": "second injection", "Type": "TREATMENT", "BeginOffset": 299, "EndOffset": 315}, {"Id": 31, "BeginOffset": 318, "EndOffset": 325, "Score": 0.9929525256156921, "Text": "1 month", "Category": "TIME_EXPRESSION", "Type": "TIME_TO_PROCEDURE_NAME", "Traits": [], "Attributes": [{"Type": "PROCEDURE_NAME", "Score": 0.6868440508842468, "RelationshipScore": 0.5666804313659668, "RelationshipType": "OVERLAP", "Id": 16, "BeginOffset": 342, "EndOffset": 351, "Text": "injection", "Category": "TEST_TREATMENT_PROCEDURE", "Traits": []}]}, {"Text": "the first injection", "Type": "TREATMENT", "BeginOffset": 332, "EndOffset": 351}, {"Text": "third injection", "Type": "TREATMENT", "BeginOffset": 355, "EndOffset": 370}, {"Id": 32, "BeginOffset": 373, "EndOffset": 381, "Score": 0.9879399538040161, "Text": "2 months", "Category": "TIME_EXPRESSION", "Type": "TIME_TO_PROCEDURE_NAME", "Traits": [], "Attributes": [{"Type": "PROCEDURE_NAME", "Score": 0.3620891869068146, "RelationshipScore": 0.9650435447692871, "RelationshipType": "OVERLAP", "Id": 17, "BeginOffset": 361, "EndOffset": 370, "Text": "injection", "Category": "TEST_TREATMENT_PROCEDURE", "Traits": []}]}, {"Text": "the first injection", "Type": "TREATMENT", "BeginOffset": 388, "EndOffset": 407}, {"Text": "fourth injection", "Type": "TREATMENT", "BeginOffset": 411, "EndOffset": 427}, {"Text": "6", "Type": "NUMBER", "BeginOffset": 430, "EndOffset": 431}, {"Text": "the first injection", "Type": "TREATMENT", "BeginOffset": 445, "EndOffset": 464}, {"Text": "the next injections", "Type": "TREATMENT", "BeginOffset": 530, "EndOffset": 549}, {"Id": 22, "BeginOffset": 579, "EndOffset": 588, "Score": 0.48347175121307373, "Text": "injection", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "PROCEDURE_NAME", "Traits": []}, {"Id": 5, "BeginOffset": 592, "EndOffset": 599, "Score": 0.4915304481983185, "Text": "fendrix", "Category": "MEDICATION", "Type": "BRAND_NAME", "Traits": []}, {"Text": "the next injections", "Type": "TREATMENT", "BeginOffset": 601, "EndOffset": 620}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 637, "EndOffset": 644}, {"Id": 24, "BeginOffset": 666, "EndOffset": 685, "Score": 0.9343761801719666, "Text": "hepatitis b vaccine", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Text": "\"booster\" injections", "Type": "TREATMENT", "BeginOffset": 739, "EndOffset": 759}, {"Id": 33, "BeginOffset": 760, "EndOffset": 773, "Score": 0.9812451601028442, "Text": "in the future", "Category": "TIME_EXPRESSION", "Type": "TIME_TO_TREATMENT_NAME", "Traits": [], "Attributes": [{"Type": "TREATMENT_NAME", "Score": 0.404872864484787, "RelationshipScore": 0.989700198173523, "RelationshipType": "OVERLAP", "Id": 25, "BeginOffset": 740, "EndOffset": 759, "Text": "booster\" injections", "Category": "TEST_TREATMENT_PROCEDURE", "Traits": []}]}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 775, "EndOffset": 782}, {"Id": 26, "BeginOffset": 805, "EndOffset": 812, "Score": 0.3284991681575775, "Text": "booster", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Id": 27, "BeginOffset": 851, "EndOffset": 870, "Score": 0.965510368347168, "Text": "hepatitis b vaccine", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Id": 28, "BeginOffset": 906, "EndOffset": 915, "Score": 0.280814528465271, "Text": "injection", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "PROCEDURE_NAME", "Traits": []}, {"Text": "four injections", "Type": "TREATMENT", "BeginOffset": 1008, "EndOffset": 1023}, {"Text": "the disease", "Type": "PROBLEM", "BeginOffset": 1072, "EndOffset": 1083}]}, "Section_4": {"Title": "4. possible side effects", "Section_Content": "like all medicines, this vaccine can cause side effects, although not everybody gets them. the following side effects may happen with this vaccine. their frequency is defined using the conventions listed below: very common (these may occur with more than 1 in 10 doses of the vaccine) headache feeling tired pain or discomfort where the injection was given. common (these may occur with up to 1 in 10 doses of the vaccine) redness or swelling where the injection was given fever stomach and digestion problems. uncommon (these may occur with up to 1 in 100 doses of the vaccine) chills red, raised skin rash other reactions where the injection was given. rare (these may occur with up to 1 in 1,000 doses of the vaccine) allergy hot flushes feeling dizzy feeling thirsty feeling nervous infection caused by a virus back pain, swelling of your tendons. additionally, the following side effects have also been reported with other hepatitis b vaccines: very rare (these may occur with up to 1 in 10,000 doses of the vaccine) fits fainting problems with the nerves of your eye (optic neuritis) multiple sclerosis loss of feeling or problems moving some parts of your body severe headache with a stiff neck numbness or weakness of the arms and legs (neuropathy), inflammation of nerves (neuritis), weakness and paralysis in the extremities and often progressing to the chest and face (guillain-barr\u00e9 syndrome), swelling or infection of the brain (encephalitis, encephalopathy). allergic reactions, including anaphylactoid reactions. these may be local or widespread rashes that may be itchy or blistering, swelling of the eyes and face, difficulty in breathing or swallowing, a sudden drop in blood pressure and loss of consciousness. such reactions may occur before leaving the doctor's surgery. however, you should seek immediate treatment in any event. reporting of side effects if you get any side effects, talk to your doctor or pharmacist. this includes any possible side effects not listed in this leaflet. you can also report side effects directly via the national reporting system listed in appendix v. by reporting side effects you can help provide more information on the safety of this medicine.", "Entity_Recognition": [{"Text": "fendrix", "Type": "PRODUCT_NAME", "BeginOffset": 0, "EndOffset": 0}, {"Text": "all medicines", "Type": "TREATMENT", "BeginOffset": 5, "EndOffset": 18}, {"Text": "this vaccine", "Type": "TREATMENT", "BeginOffset": 20, "EndOffset": 32}, {"Id": 18, "BeginOffset": 43, "EndOffset": 55, "Score": 0.9675864577293396, "Text": "side effects", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.5731257796287537}]}, {"Id": 19, "BeginOffset": 105, "EndOffset": 117, "Score": 0.8248975276947021, "Text": "side effects", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.7083487510681152}]}, {"Text": "this vaccine", "Type": "TREATMENT", "BeginOffset": 134, "EndOffset": 146}, {"Id": 20, "BeginOffset": 154, "EndOffset": 163, "Score": 0.2591514587402344, "Text": "frequency", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": []}, {"Text": "1", "Type": "NUMBER", "BeginOffset": 255, "EndOffset": 256}, {"Text": "10", "Type": "NUMBER", "BeginOffset": 260, "EndOffset": 262}, {"Id": 73, "BeginOffset": 276, "EndOffset": 283, "Score": 0.3176310062408447, "Text": "vaccine", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Id": 21, "BeginOffset": 285, "EndOffset": 293, "Score": 0.9797878861427307, "Text": "headache", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.7333076000213623}]}, {"Text": "tired pain", "Type": "PROBLEM", "BeginOffset": 302, "EndOffset": 312}, {"Id": 24, "BeginOffset": 316, "EndOffset": 326, "Score": 0.9932150840759277, "Text": "discomfort", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.9134774804115295}]}, {"Text": "the injection", "Type": "TREATMENT", "BeginOffset": 333, "EndOffset": 346}, {"Text": "1", "Type": "NUMBER", "BeginOffset": 393, "EndOffset": 394}, {"Text": "10", "Type": "NUMBER", "BeginOffset": 398, "EndOffset": 400}, {"Text": "the vaccine", "Type": "TREATMENT", "BeginOffset": 410, "EndOffset": 421}, {"Id": 25, "BeginOffset": 423, "EndOffset": 430, "Score": 0.9740493893623352, "Text": "redness", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8602110743522644}]}, {"Id": 26, "BeginOffset": 434, "EndOffset": 442, "Score": 0.995560884475708, "Text": "swelling", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.886339545249939}]}, {"Text": "the injection", "Type": "TREATMENT", "BeginOffset": 449, "EndOffset": 462}, {"Text": "fever stomach", "Type": "PROBLEM", "BeginOffset": 473, "EndOffset": 486}, {"Id": 28, "BeginOffset": 491, "EndOffset": 509, "Score": 0.5512698888778687, "Text": "digestion problems", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8790196776390076}]}, {"Text": "1", "Type": "NUMBER", "BeginOffset": 548, "EndOffset": 549}, {"Text": "100", "Type": "NUMBER", "BeginOffset": 553, "EndOffset": 556}, {"Text": "the vaccine", "Type": "TREATMENT", "BeginOffset": 566, "EndOffset": 577}, {"Id": 29, "BeginOffset": 579, "EndOffset": 585, "Score": 0.9378141760826111, "Text": "chills", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8986522555351257}]}, {"Text": "red", "Type": "PROBLEM", "BeginOffset": 586, "EndOffset": 589}, {"Text": "raised skin rash other reactions", "Type": "PROBLEM", "BeginOffset": 591, "EndOffset": 623}, {"Text": "the injection", "Type": "TREATMENT", "BeginOffset": 630, "EndOffset": 643}, {"Text": "1", "Type": "NUMBER", "BeginOffset": 688, "EndOffset": 689}, {"Text": "1,000", "Type": "NUMBER", "BeginOffset": 693, "EndOffset": 698}, {"Text": "the vaccine", "Type": "TREATMENT", "BeginOffset": 708, "EndOffset": 719}, {"Text": "allergy", "Type": "PROBLEM", "BeginOffset": 721, "EndOffset": 728}, {"Id": 31, "BeginOffset": 729, "EndOffset": 748, "Score": 0.36140403151512146, "Text": "hot flushes feeling", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": []}, {"Id": 32, "BeginOffset": 749, "EndOffset": 754, "Score": 0.681268036365509, "Text": "dizzy", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.5684653520584106}]}, {"Id": 33, "BeginOffset": 755, "EndOffset": 770, "Score": 0.8558265566825867, "Text": "feeling thirsty", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.9414271116256714}]}, {"Id": 34, "BeginOffset": 771, "EndOffset": 796, "Score": 0.6985940933227539, "Text": "feeling nervous infection", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8844398856163025}]}, {"Text": "a virus back pain", "Type": "PROBLEM", "BeginOffset": 807, "EndOffset": 824}, {"Text": "swelling of your tendons", "Type": "PROBLEM", "BeginOffset": 826, "EndOffset": 850}, {"Id": 37, "BeginOffset": 880, "EndOffset": 892, "Score": 0.8888412117958069, "Text": "side effects", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8098264336585999}]}, {"Id": 74, "BeginOffset": 928, "EndOffset": 948, "Score": 0.8624236583709717, "Text": "hepatitis b vaccines", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Text": "1", "Type": "NUMBER", "BeginOffset": 988, "EndOffset": 989}, {"Text": "10,000", "Type": "NUMBER", "BeginOffset": 993, "EndOffset": 999}, {"Text": "the vaccine", "Type": "TREATMENT", "BeginOffset": 1009, "EndOffset": 1020}, {"Text": "fainting problems", "Type": "PROBLEM", "BeginOffset": 1027, "EndOffset": 1044}, {"Id": 4, "BeginOffset": 1054, "EndOffset": 1060, "Score": 0.7207563519477844, "Text": "nerves", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Text": "your eye (optic neuritis", "Type": "PROBLEM", "BeginOffset": 1064, "EndOffset": 1088}, {"Text": "multiple sclerosis loss of feeling", "Type": "PROBLEM", "BeginOffset": 1090, "EndOffset": 1124}, {"Id": 43, "BeginOffset": 1128, "EndOffset": 1143, "Score": 0.6416620016098022, "Text": "problems moving", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.6933231353759766}], "Attributes": [{"Type": "SYSTEM_ORGAN_SITE", "Score": 0.9937368631362915, "RelationshipScore": 0.4972096383571625, "RelationshipType": "SYSTEM_ORGAN_SITE", "Id": 5, "BeginOffset": 1069, "EndOffset": 1072, "Text": "eye", "Category": "ANATOMY", "Traits": []}]}, {"Text": "your body severe headache", "Type": "PROBLEM", "BeginOffset": 1158, "EndOffset": 1183}, {"Text": "a stiff neck numbness", "Type": "PROBLEM", "BeginOffset": 1189, "EndOffset": 1210}, {"Text": "weakness of the arms and legs (neuropathy)", "Type": "PROBLEM", "BeginOffset": 1214, "EndOffset": 1256}, {"Text": "inflammation of nerves (neuritis)", "Type": "PROBLEM", "BeginOffset": 1258, "EndOffset": 1291}, {"Id": 50, "BeginOffset": 1293, "EndOffset": 1301, "Score": 0.9928544163703918, "Text": "weakness", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.8816824555397034}], "Attributes": [{"Type": "SYSTEM_ORGAN_SITE", "Score": 0.9958639144897461, "RelationshipScore": 0.9230201244354248, "RelationshipType": "SYSTEM_ORGAN_SITE", "Id": 12, "BeginOffset": 1323, "EndOffset": 1334, "Text": "extremities", "Category": "ANATOMY", "Traits": []}]}, {"Text": "paralysis in the extremities", "Type": "PROBLEM", "BeginOffset": 1306, "EndOffset": 1334}, {"Id": 13, "BeginOffset": 1364, "EndOffset": 1369, "Score": 0.9919915795326233, "Text": "chest", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Id": 14, "BeginOffset": 1374, "EndOffset": 1378, "Score": 0.9814444780349731, "Text": "face", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Id": 52, "BeginOffset": 1380, "EndOffset": 1403, "Score": 0.8734436631202698, "Text": "guillain-barr\u00e9 syndrome", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.9245747923851013}], "Attributes": [{"Type": "SYSTEM_ORGAN_SITE", "Score": 0.9919915795326233, "RelationshipScore": 0.5943211913108826, "RelationshipType": "SYSTEM_ORGAN_SITE", "Id": 13, "BeginOffset": 1364, "EndOffset": 1369, "Text": "chest", "Category": "ANATOMY", "Traits": []}]}, {"Id": 53, "BeginOffset": 1406, "EndOffset": 1414, "Score": 0.9881219863891602, "Text": "swelling", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.7978488206863403}], "Attributes": [{"Type": "SYSTEM_ORGAN_SITE", "Score": 0.9969778060913086, "RelationshipScore": 0.9223209023475647, "RelationshipType": "SYSTEM_ORGAN_SITE", "Id": 15, "BeginOffset": 1435, "EndOffset": 1440, "Text": "brain", "Category": "ANATOMY", "Traits": []}]}, {"Text": "infection of the brain", "Type": "PROBLEM", "BeginOffset": 1418, "EndOffset": 1440}, {"Id": 55, "BeginOffset": 1442, "EndOffset": 1454, "Score": 0.9473629593849182, "Text": "encephalitis", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.8771324753761292}]}, {"Id": 56, "BeginOffset": 1456, "EndOffset": 1470, "Score": 0.9920409321784973, "Text": "encephalopathy", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "DIAGNOSIS", "Score": 0.9040467143058777}], "Attributes": [{"Type": "SYSTEM_ORGAN_SITE", "Score": 0.9969778060913086, "RelationshipScore": 0.519501268863678, "RelationshipType": "SYSTEM_ORGAN_SITE", "Id": 15, "BeginOffset": 1435, "EndOffset": 1440, "Text": "brain", "Category": "ANATOMY", "Traits": []}]}, {"Id": 57, "BeginOffset": 1473, "EndOffset": 1491, "Score": 0.9290559887886047, "Text": "allergic reactions", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.4886525869369507}, {"Name": "DIAGNOSIS", "Score": 0.6113166213035583}]}, {"Id": 58, "BeginOffset": 1503, "EndOffset": 1526, "Score": 0.900420069694519, "Text": "anaphylactoid reactions", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.5901485681533813}, {"Name": "DIAGNOSIS", "Score": 0.551033079624176}]}, {"Text": "widespread rashes", "Type": "PROBLEM", "BeginOffset": 1550, "EndOffset": 1567}, {"Id": 60, "BeginOffset": 1580, "EndOffset": 1585, "Score": 0.9373137950897217, "Text": "itchy", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.7970743179321289}]}, {"Id": 61, "BeginOffset": 1589, "EndOffset": 1599, "Score": 0.9858115911483765, "Text": "blistering", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.842263400554657}], "Attributes": [{"Type": "SYSTEM_ORGAN_SITE", "Score": 0.9974613189697266, "RelationshipScore": 0.698026180267334, "RelationshipType": "SYSTEM_ORGAN_SITE", "Id": 16, "BeginOffset": 1617, "EndOffset": 1621, "Text": "eyes", "Category": "ANATOMY", "Traits": []}, {"Type": "SYSTEM_ORGAN_SITE", "Score": 0.9965915679931641, "RelationshipScore": 0.8229490518569946, "RelationshipType": "SYSTEM_ORGAN_SITE", "Id": 17, "BeginOffset": 1626, "EndOffset": 1630, "Text": "face", "Category": "ANATOMY", "Traits": []}]}, {"Text": "swelling of the eyes and face", "Type": "PROBLEM", "BeginOffset": 1601, "EndOffset": 1630}, {"Text": "difficulty in breathing or swallowing", "Type": "PROBLEM", "BeginOffset": 1632, "EndOffset": 1669}, {"Text": "a sudden drop in blood pressure", "Type": "PROBLEM", "BeginOffset": 1671, "EndOffset": 1702}, {"Id": 67, "BeginOffset": 1707, "EndOffset": 1728, "Score": 0.9740495085716248, "Text": "loss of consciousness", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.921407163143158}], "Attributes": [{"Type": "ACUITY", "Score": 0.3789188861846924, "RelationshipScore": 0.8031057119369507, "RelationshipType": "ACUITY", "Id": 65, "BeginOffset": 1673, "EndOffset": 1679, "Text": "sudden", "Category": "MEDICAL_CONDITION", "Traits": []}]}, {"Text": "such reactions", "Type": "PROBLEM", "BeginOffset": 1730, "EndOffset": 1744}, {"Text": "'s surgery", "Type": "TREATMENT", "BeginOffset": 1780, "EndOffset": 1790}, {"Text": "immediate treatment", "Type": "TREATMENT", "BeginOffset": 1817, "EndOffset": 1836}, {"Id": 68, "BeginOffset": 1864, "EndOffset": 1876, "Score": 0.9274786710739136, "Text": "side effects", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.7712569236755371}]}, {"Id": 69, "BeginOffset": 1892, "EndOffset": 1904, "Score": 0.9097501635551453, "Text": "side effects", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.7565196752548218}]}, {"Id": 70, "BeginOffset": 1968, "EndOffset": 1980, "Score": 0.9508264064788818, "Text": "side effects", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.6608158349990845}]}, {"Id": 77, "BeginOffset": 2029, "EndOffset": 2041, "Score": 0.7985130548477173, "Text": "side effects", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.590618371963501}]}, {"Id": 76, "BeginOffset": 2095, "EndOffset": 2103, "Score": 0.4062059819698334, "Text": "appendix", "Category": "ANATOMY", "Type": "SYSTEM_ORGAN_SITE", "Traits": []}, {"Id": 78, "BeginOffset": 2120, "EndOffset": 2132, "Score": 0.7559387683868408, "Text": "side effects", "Category": "MEDICAL_CONDITION", "Type": "DX_NAME", "Traits": [{"Name": "SYMPTOM", "Score": 0.6917688846588135}]}, {"Text": "this medicine", "Type": "TREATMENT", "BeginOffset": 2188, "EndOffset": 2201}]}, "Section_5": {"Title": "5. how to store fendrix", "Section_Content": " keep this vaccine out of the sight and reach of children. do not use this vaccine after the expiry date which is stated on the carton. the expiry date refers to the last day of that month. store in a refrigerator (2 - 8). store in the original package in order to protect from light. do not freeze. freezing destroys the vaccine. do not throw away any medicines via wastewater or household waste. ask your pharmacist how to throw away medicines you no longer use. these measures will help to protect the environment.", "Entity_Recognition": [{"Text": "fendrix", "Type": "PRODUCT_NAME", "BeginOffset": 0, "EndOffset": 0}, {"Text": "this vaccine", "Type": "TREATMENT", "BeginOffset": 6, "EndOffset": 18}, {"Text": "this vaccine", "Type": "TREATMENT", "BeginOffset": 70, "EndOffset": 82}, {"Id": 2, "BeginOffset": 300, "EndOffset": 317, "Score": 0.7330852746963501, "Text": "freezing destroys", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Id": 3, "BeginOffset": 322, "EndOffset": 329, "Score": 0.6925433278083801, "Text": "vaccine", "Category": "TEST_TREATMENT_PROCEDURE", "Type": "TREATMENT_NAME", "Traits": []}, {"Text": "these measures", "Type": "TREATMENT", "BeginOffset": 465, "EndOffset": 479}]}, "Section_6": {"Title": "6. contents of the pack and other information", "Section_Content": "what fendrix contains the active substance in 1 dose (0.5 ml) of fendrix is: hepatitis b surface antigen 1, 2, 3 20 micrograms 1adjuvanted by as04c containing: - 3-o-desacyl-4'- monophosphoryl lipid a (mpl) 2 50 micrograms 2adsorbed on aluminium phosphate (0.5 milligrams al3+ in total) 3produced in yeast cells (saccharomyces cerevisiae) by recombinant dna technology. the other ingredients in fendrix are: sodium chloride, water for injections. what fendrix looks like and contents of the pack suspension for injection in a prefilled syringe. fendrix is a white, milky suspension presented in a glass prefilled syringe (0.5 ml). fendrix is available in packs of 1 (with or without a separate needle) and in a pack size of 10 without needles. not all pack sizes may be marketed.", "Entity_Recognition": [{"Text": "fendrix", "Type": "PRODUCT_NAME", "BeginOffset": 0, "EndOffset": 0}, {"Text": "1", "Type": "NUMBER", "BeginOffset": 46, "EndOffset": 47}, {"Id": 1, "BeginOffset": 65, "EndOffset": 72, "Score": 0.5045384764671326, "Text": "fendrix", "Category": "MEDICATION", "Type": "BRAND_NAME", "Traits": [], "Attributes": [{"Type": "DOSAGE", "Score": 0.4023367464542389, "RelationshipScore": 0.9995972514152527, "RelationshipType": "DOSAGE", "Id": 2, "BeginOffset": 113, "EndOffset": 126, "Text": "20 micrograms", "Category": "MEDICATION", "Traits": []}]}, {"Text": "hepatitis b surface antigen", "Type": "TEST", "BeginOffset": 77, "EndOffset": 104}, {"Text": "1", "Type": "NUMBER", "BeginOffset": 105, "EndOffset": 106}, {"Text": "2", "Type": "NUMBER", "BeginOffset": 108, "EndOffset": 109}, {"Text": "3", "Type": "NUMBER", "BeginOffset": 111, "EndOffset": 112}, {"Text": "20", "Type": "NUMBER", "BeginOffset": 113, "EndOffset": 115}, {"Text": "3", "Type": "NUMBER", "BeginOffset": 162, "EndOffset": 163}, {"Id": 3, "BeginOffset": 166, "EndOffset": 205, "Score": 0.7682294845581055, "Text": "desacyl-4'- monophosphoryl lipid a (mpl", "Category": "MEDICATION", "Type": "GENERIC_NAME", "Traits": [], "Attributes": [{"Type": "DOSAGE", "Score": 0.5734546184539795, "RelationshipScore": 0.9999619722366333, "RelationshipType": "DOSAGE", "Id": 4, "BeginOffset": 207, "EndOffset": 222, "Text": "2 50 micrograms", "Category": "MEDICATION", "Traits": []}]}, {"Text": "2", "Type": "NUMBER", "BeginOffset": 207, "EndOffset": 208}, {"Text": "50", "Type": "NUMBER", "BeginOffset": 209, "EndOffset": 211}, {"Id": 5, "BeginOffset": 236, "EndOffset": 255, "Score": 0.7827001810073853, "Text": "aluminium phosphate", "Category": "MEDICATION", "Type": "GENERIC_NAME", "Traits": [], "Attributes": [{"Type": "DOSAGE", "Score": 0.4738362431526184, "RelationshipScore": 0.9999158382415771, "RelationshipType": "DOSAGE", "Id": 6, "BeginOffset": 257, "EndOffset": 271, "Text": "0.5 milligrams", "Category": "MEDICATION", "Traits": []}]}, {"Text": "saccharomyces cerevisiae", "Type": "TREATMENT", "BeginOffset": 313, "EndOffset": 337}, {"Id": 7, "BeginOffset": 408, "EndOffset": 423, "Score": 0.9241645932197571, "Text": "sodium chloride", "Category": "MEDICATION", "Type": "GENERIC_NAME", "Traits": []}, {"Text": "injections", "Type": "TREATMENT", "BeginOffset": 435, "EndOffset": 445}, {"Text": "the pack suspension", "Type": "TREATMENT", "BeginOffset": 487, "EndOffset": 506}, {"Text": "a prefilled syringe", "Type": "TREATMENT", "BeginOffset": 524, "EndOffset": 543}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 545, "EndOffset": 552}, {"Text": "a glass prefilled syringe", "Type": "TREATMENT", "BeginOffset": 595, "EndOffset": 620}, {"Text": "fendrix", "Type": "TREATMENT", "BeginOffset": 631, "EndOffset": 638}, {"Text": "1", "Type": "NUMBER", "BeginOffset": 664, "EndOffset": 665}, {"Text": "a separate needle", "Type": "TREATMENT", "BeginOffset": 683, "EndOffset": 700}, {"Text": "a pack size", "Type": "TREATMENT", "BeginOffset": 709, "EndOffset": 720}, {"Text": "10", "Type": "NUMBER", "BeginOffset": 724, "EndOffset": 726}]}}